WO2007115657A2

WO2007115657A2 - Bleaching and coloring agents well tolerated by the skin

Info

Publication number: WO2007115657A2
Application number: PCT/EP2007/002527
Authority: WO
Inventors: Horst Höffkes; Georg KNÜBEL; Claudia Brockmann; Denise Fuhr
Original assignee: Henkel Ag & Co. Kgaa
Priority date: 2006-04-07
Filing date: 2007-03-22
Publication date: 2007-10-18
Also published as: WO2007115657A3; DE102006016817A1

Abstract

Disclosed are agents for bleaching human hair. Said agents contain 5 to 70 percent by weight of at least one solid peroxo compound selected among ammonium persulfates, alkali metal persulfates, ammonium peroxidisulfates, and alkali metal peroxidisulfates, and 0.05 to 5 percent by weight of at least one cyanate of formula M+ [OCN]-, wherein M+ represents K+, Na+, Li+, NH4+, 1/2 Ca2+, 1/2 Mg2+, or 1/2 Zn2+, and/or 0.05 to 5 percent by weight of at least one compound of formula H2N-C(O)-L, wherein L represents a group that can be displaced by the anion -OOH, the percentages being in relation to the weight of the agents. The inventive agents feature a reduced reaction time while reducing the risk of irritation.

Description

"Whitening and / or coloring with good skin compatibility"

The invention relates to a blonding agent for human hair, in particular a bleaching agent for human hair, which is in paste or powder form.

The change in shape and color of the hair is an important area of modern cosmetics dar. Thus, the appearance of the hair can be adapted to both current fashion trends and the individual desires of each person. In this case, permanent wave and other hair-changing methods can be used almost independently of the type of hair to be treated. In contrast, dyeing and in particular bleaching processes are limited to certain initial hair colors. Thus, for lightening procedures, the so-called Blondierverfahren, are essentially only dark blond or lighter hair. The basics of the bleaching processes are known to those skilled in the art and may be described in relevant monographs, e.g. by Kh. Schrader, Basics and Formulations of Cosmetics, 2nd edition, 1989, Dr. med. Alfred Hüthig Verlag, Heidelberg, or W. Umbach (ed.), Cosmetics, 2nd edition, 1995, Georg Thieme Verlag, Stuttgart, New York, be read.

Thus, solid or paste-like preparations with solid oxidizing agents are usually mixed with a dilute hydrogen peroxide solution immediately before use. This mixture is then applied to the hair and rinsed again after a certain exposure time.

The said preparations, which are mixed before use with a hydrogen peroxide solution, are hereinafter referred to as "Blondiermittel" or "Blondierpulver". Unless otherwise stated, all listed quantities relate exclusively to these preparations.

Neither the pasty nor the powdered bleaching agents that are on the market today can be considered optimal. While the blonding effect on the hair can be considered satisfactory, there are still a number of disadvantages and problems both in the manufacture and in the handling of these agents. In the case of pasty agents, which are adjusted to high viscosity for stability reasons, the Dosage and the mixing behavior in the hydrogen peroxide solution is not yet satisfactory. In the case of powdered products, the dust behavior, both in the packaging and in the application, as well as the mixing behavior in the application are at the center of the improvement efforts. In addition, the duration of exposure to the hair to achieve complete coloration is between about 30 and 40 minutes. It is obvious that users have a need to reduce this exposure time.

It has now been found that certain drug combinations can be incorporated with particular advantage in Blondiermittel and lead to a reduction in exposure times and the irritation potential of these agents.

The invention relates in a first embodiment to an agent for bleaching human hair, containing - in each case based on its weight - a) 5 to 70 wt .-% of at least one solid peroxo compound which is selected from ammonium and alkali metal persulfates and peroxydisulfates , b1) 0.05 to 5 wt .-% of at least one cyanate of the formula

M ⁺ [OCN] ^' in which M ^{+ stands} for K ⁺ , Na ⁺ , Li ⁺ or NH ₄ ⁺ or Vz Ca ²⁺ , Vz Mg ²⁺ or Vz Zn ²⁺ and / or b2) 0.05 to 5% by wt .-% of at least one compound of the formula

H ₂ NC (O) -L in which L stands for a group displaceable by the anion ^" OOH.

The bleaching compositions according to the invention contain as the first compulsory component a solid peroxo compound which is selected from ammonium and alkali metal persulfates and peroxidisulfates. The selection of this peroxo compound is in principle not limited; Typical peroxo compounds known to the person skilled in the art are, for example, ammonium peroxydisulfate, potassium peroxodisulfate, sodium peroxodisulfate, ammonium persulfate, potassium persulfate, sodium persulfate. Among these peroxo compounds, which can also be used in combination, according to the invention, the peroxydisulfates are preferred, in particular combinations of at least two peroxydisulfates.

Preferred agents according to the invention are therefore characterized in that they contain sodium peroxydisulfate and / or potassium peroxodisulfate and / or ammonium peroxodisulfate, preferred agents containing at least two different peroxidisulfates. Furthermore, use within narrower ranges is preferred, so that preferred agents according to the invention are characterized in that they contain from 6 to 65% by weight, preferably from 7.5 to 60% by weight, more preferably 8 to 55 wt .-% and in particular 10 to 50 wt .-% Peroxidisulfa.t (e) included.

As a further component, the bleaching compositions according to the invention may contain an alkalizing agent which serves to adjust the alkaline pH of the application mixture. This is preferred according to the invention.

According to the invention, the usual alkalizing agents known to the person skilled in the art for bleaching agents, such as ammonium, alkali metal and alkaline earth metal hydroxides, carbonates, bicarbonates, hydroxycarbonates, silicates, in particular metasilicates, and also alkali metal phosphates, can be used. Short-chain amines such as monoethanolamines, 3-amino-2-methylpropanol or alkaline-reacting amino acids such as arginine, ornithine and lysine can also be used. In a preferred embodiment, the bleaching powders according to the invention contain at least two different alkalizing agents. In this case, mixtures of, for example, a metasilicate and a hydroxycarbonate may be preferred.

The bleaching compositions according to the invention preferably comprise alkalizing agents in amounts of from 1 to 30% by weight, in particular from 2 to 25% by weight.

As a second essential ingredient, the bleaching agents according to the invention contain from 0.05 to 5% by weight of at least one cyanate of the formula M ⁺ [OCN] ^' in M ⁺ for K ⁺ , Na ⁺ , Li ⁺ or NH ₄ ⁺ or V-Ca ^{2 +} , VΣ Mg ²⁺ or>. Zn ²⁺ and / or 0.05 to 5 wt .-% of at least one compound of the formula H ₂ NC (O) -L, in which L is a displaceable by the anion ^" OOH group.

According to the invention, therefore, cyanates may be potassium cyanate, KOCN, and / or sodium cyanate, NaOCN, and / or lithium cyanate, LiOCN, and / or ammonium cyanate, NH ₄ OCN, and / or calcium cyanate, Ca (OCN) ₂ , and / or magnesium cyanate, Mg ( OCN) ₂ , and / or zinc cyanate, Zn (OCN) ₂ , are used.

Agents preferred according to the invention are characterized in that they contain 0.075 to 4% by weight, preferably 0.1 to 2.5% by weight and in particular 0.2 to 1% by weight of sodium cyanate and / or potassium cyanate and / or ammonium cyanate with sodium cyanate being particularly preferred.

Instead of cyanates or in combination with them, it is also possible for compounds of the formula H ₂ NC (O) -L in which L is a group displaceable by the anion ^" OOH to be present in the agents according to the invention in that they contain from 0.075 to 4% by weight, preferably from 0.1 to 3.5% by weight and in particular from 0.2 to 3% by weight of at least one compound of the formula

H ₂ NC (O) -L in which L is selected from -S-CH ₂ -COOH ₁ -S- (CH ₂ ) ₃ SO ₃ H, -S- (CH ₂ ) ₂ -NH ₂ , -OCH ₃ , -O- (C ₆ H ₄ J-SO ₃ M, -Q ⁺ , -NH-OH ₁ -O-C (O) -R ¹ , -O-C (O) -H ₁ -O-CH (OH) ₂ , -SO ₃ M ₁ -PH (O) OH ₁ -P (O) (OH) ₂ , - (NH-Glucosamine) _n , -NH-C (O) -NH ₂ , -NH-NH ₂ , -NH-CN ₁ -P (OH) (O) -C (O) NH ₂ , -SCN ₁ -OCN, -SC (NH) NH ₂ , OONa

and M is -H ₁ Na, K, NH ₄ , Q is selected from quaternary ammonium radicals, heteroaryl radicals or non-aromatic heterocycles formed from tertiary amines and R ^{1 is} --H, -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ J ₂ CH ₃ , -CH (CH ₃ J ₂ or another alkyl group.

Particularly preferred agents according to the invention contain from 0.075 to 4% by weight, preferably from 0.1 to 3.5% by weight and in particular from 0.2 to 3% by weight of at least one of the compounds listed below:

- H ₂ NC (O) -S-CH ₂ -COOH. H ₂ NC (O) -S- (CH ₂ ) ₂ -NH ₂

- H ₂ NC (O) -S- (CH ₂ J ₃ SO ₃ Na

- H ₂ NC (O) -S- (CHz) ₃ SO ₃ K.

- H ₂ NC (O) -S- (CH ₂ ) ₃ SO ₃ NH ₄

- H ₂ NC (O) -SO ₃ H

- H ₂ NC (O) -SO ₃ Na

- H ₂ NC (O) -SO ₃ K

- H ₂ NC (O) -SO ₃ NH ₄

- H ₂ NC (O) -O- (C ₆ H ₄ ) -SO ₃ H

- H ₂ NC (O) -O- (C ₆ H ₄ ) -SO ₃ Na

- H ₂ NC (O) -O- (C ₆ H ₄ ) -SO ₃ K

- H ₂ NC (O) -O- (C ₆ H ₄ ) -SO ₃ NH ₄

- H ₂ NC (O) -OC (O) -H

^" H ₂ NC (O) -OC (O) -CH ₃ ^" H ₂ NC (O) -OC (O) -CH ₂ CH ₃ , ^ε OSO- ³ HO-O ^ε H ₊ ^e ( ^s H ⁹ O) N- (O) O-N ³ H

, ^E OSO- ^z H0-0 ^ε H ₊ ^ε ( ^ε ( ^ε H0) H0) N- (θ) 0-N ^z H

, OSO ^ε ^ε ^ε H H0-0 ₊ ^ε ^(ε H0 ^ε ⁽³ H0)) N- (θ) 0 N ^z H

, ^ε OSO- ³ H0-0 ^ε H ₊ ^ε ( ^e H0 ³ H0) N- (θ) 0-N ^z H

, OSO ^ε ^ε ^ε H H0-0 ₊ ^ε ^(ε H0) N- (θ) 0 "N ³ H

, ^ε 0S0-0 ^ε H ₊ ^ε (μd- ^z H0) N- (θ) 0 N ^z H

, ^ε 0 ^ε OSO-H / ⁽⁹ H ⁹ O) N- (O) ON ² H

, ^ε 0S0-0 ^ε ^ε H ₊ ⁽³ ^(ε Hθ) H0) N- (θ) 0 "N ³ H

, ^ε 0 ^ε OSO-H ₊ ^ε ^(ε ³ H0 (H0 ^ε)) N- (θ) 0 N ^z H

, ^ε 0S0 "0 ^ε H ₊ ^ε ( ^ε H0 ^z H0) N- (θ) 0" N ³ H

, ^ε 0 ^ε OSO-H ₊ ^ε ^(ε H0) N- (θ) 0-N ^ε H

.Ja ₊ ^ε (Md- ^ε H0) N- (θ) 0-N ^ε H

JQ / ⁽⁹ H ⁹ O) N- (O) ON ³ H

.Ja ₊ ^ε ( ^z ( ^ε H0) H0) N- (0) 0 "N ^∈ H

.Jg ₊ ^ε ^(ε H0 ^z ^(z H0)) N- (0) 0-N ^z H

JQ ₊ ^ε ( ^ε H0 ^z H0) N- (θ) 0 -N ^z H

- ^J g ₊ ^ε ( ^ε H0) N- (θ) 0 -N ^z H

.10 ₊ ^ε (Md- ^z H0) N- (θ) 0 -N ^z H

.10 / ⁽⁹ H ⁹ O) N- (O) ON ³ H

.10 / ^(z ^(ε H0) H0) N- (θ) 0 "N ^z H

.10 / ^(ε H0 ^z ^(z H0)) N- (θ) 0-N ³ H

.10 / ( ^ε H0 ^z H0) N- (0) 0-N ^z H

J0 / ^(ε H0) N- (0) 0-N ^z H

³ HN (HN) OS- (O) ON ³ H

NOO- (O) ON ³ H

NOS- (O) ON ³ H

³ HN (O) 0- (O) (HO) d (O) 0 ^3-N H

NO-HN- (O) ON ³ H

³ HN-HN- (O) ON ³ H

³ HN- (O) O-HN- (O) ON ³ H

³ (HO) (O) d- (O) O "N ³ H

HO (O) Hd- (O) ON ³ H

^Z (HO) HO-0- (0) 0-N ³ H

HO-HN- (O) ON ³ H H0O- ^ε (θ) 0-N H ³ ^z ^(ε H0) H0- (θ) 0-O- (θ) 0 ^3-N H H0 ^ε ^z ⁽³ H0Hθ) 0-O- (θ) 0 -N ^z H

LZSZOO / LOOZdΑ / ΣJd /.S9SΪΪ//.00Z OΛV H ₂ NC (O) -N (CH ₂ -Ph) ₃ ⁺ H ₃ C-CH ₂ -OSO ₃ ^"

Furthermore, it has proven to be advantageous if the bleaching according to the invention contain nonionic surfactants. Such surfactants having an HLB of 5.0 and greater are preferred. For the definition of the HLB value, explicit reference is made to the statements in Hugo Janistyn, Handbuch der Kosmetika und Riechstoffe, III. Volume: The personal care products, 2nd edition, Dr. med. Alfred Hüthig Verlag Heidelberg, 1973, pages 68-78 and Hugo Janistyn, Paperback of modern perfumery and cosmetics, 4th edition, Scientific Publishing Company m.b.H. Stuttgart, 1974, pages 466-474, as well as the original works cited therein.

Particularly preferred non-ionic surface-active substances are substances that are commercially available as solids or liquids in pure form because of their ease of processing. The definition of purity in this context does not refer to chemically pure compounds. Rather, especially when it comes to natural-based products, mixtures of different homologs can be used, for example, with different alkyl chain lengths, such as those obtained with products based on natural fats and oils. Even with alkoxylated products, mixtures of different degrees of alkoxylation are usually present. The term purity in this context refers rather to the fact that the chosen substances should preferably be free from solvents, stabilizers and other impurities.

Preferred nonionic surfactants are

- alkoxylated fatty alcohols having 8 to 22, in particular 10 to 16, carbon atoms in the fatty alkyl group and 1 to 30, in particular 1 to 15, ethylene oxide and / or

Propylene oxide units. Preferred fatty alkyl groups are, for example, lauryl, myristyl, cetyl, but also stearyl, isostearyl and oleyl groups. Particularly preferred compounds of this class are, for example, lauryl alcohol with 2 to 4 ethylene oxide units, oleyl and cetyl alcohol with 5 to 10 ethylene oxide, cetyl alcohol and stearyl alcohol and mixtures thereof with 10 to 30 ethylene oxide units and the commercial product Aethoxal ^® B (Henkel), a Lauryl alcohol with 5 ethylene oxide and 3 propylene oxide units. In addition to the usual alkoxylated fatty alcohols, it is also possible to use so-called "end-capped" compounds according to the invention In these compounds, the alkoxy group has no OH group at the end but is "closed" in the form of an ether, in particular a C 1 -C 4 -alkyl ether. , An example of such a compound is the commercially available product ^® Dehypon LT 054, a C _12th _18- fatty alcohol + 4.5 ethylene oxide-butyl ether. - alkoxylated fatty acids having 8 to 22, in particular 10 to 16, carbon atoms in the fatty acid group and 1 to 30, in particular 1 to 15, ethylene oxide and / or propylene oxide units. Preferred fatty acids are, for example, lauric, myristic, palmitic, stearic, isostearic and oleic acids.

- alkoxylated, preferably propoxylated and especially ethoxylated, mono-, di- and triglycerides. Examples of preferred compounds are glycerol monolaurate + 20 ethylene oxide and glycerol monostearate + 20 ethylene oxide.

Polyglycerol esters and alkoxylated polyglycerol esters. Preferred compounds of this class are for example poly (3) glycerol diisostearate (commercial product: Lameform ^® TGI (Henkel)) and poly (2) glycerinpolyhydroxy- stearate (commercial product: Dehymuls ^® PGPH (Henkel)).

Sorbitan fatty acid esters and alkoxylated sorbitan fatty acid esters such as sorbitan monolaurate and sorbitan monolaurate + 20 ethylene oxide (EO).

- Alkylphenols and Alkylphenolalkoxylate having 6 to 21, in particular 6 to 15, carbon atoms in the alkyl chain and 0 to 30 ethylene oxide and / or propylene oxide units. Preferred representatives of this class are, for example, nonylphenol + 4 EO, nonylphenol + 9 EO, octylphenol + 3 EO and octylphenol + 8 EO.

Particularly preferred classes of nonionic surfactants are the alkoxylated fatty alcohols, the alkoxylated fatty acids and the alkylphenols and alkylphenol alkoxylates.

Agents according to the invention which contain non-ionic surface-active substances in amounts of 1 to 5% by weight have proved to be particularly advantageous.

Furthermore, the bleaching according to the invention may contain all known in such preparations active ingredients, additives and excipients. In many cases, the agents contain at least one surfactant, wherein in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, cationic or nonionic surfactants. Anionic surfactants may be very particularly preferred. Preferred anionic surfactants are alkyl sulfates, ether carboxylic acid salts having 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule such as C ₁₂ H ₂₅ - (C ₂ H ₄ O) ₆ -CH ₂ - COONa and in particular salts of saturated and especially unsaturated C8-C22 carboxylic acids such as oleic acid, stearic acid, isostearic acid and palmitic acid.

These anionic surfactants should preferably be present in solid, in particular powder form. Very particular preference is given to solid soaps, especially sodium stearate, at room temperature. These are preferably present in amounts of from 5 to 20% by weight, in particular from 10 to 15% by weight.

Suitable nonionic surfactants are in particular C 8 -C 22 -alkyl mono- and oligoglycosides and their ethoxylated analogs. In particular, the nonethoxylated compounds have been found to be particularly suitable.

Examples of the cationic surfactants which can be used in the hair treatment compositions according to the invention are, in particular, quaternary ammonium compounds. Preference is given to ammonium halides such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, eg. Cetyltrimethylammonium chloride,

Stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride. Further cationic surfactants which can be used according to the invention are the quaternized protein hydrolysates.

Alkylamidoamines, in particular fatty acid amidoamines, such as the ^{stearylamidopropyldimethylamine} obtainable under the name Tego ^Amid® S 18, are distinguished not only by a good conditioning action but also by their good biodegradability.

Also very good biodegradability are quaternary Esterverbindungen, so-called "esterquats", such as the Distearoylethylhydroxyethylammoniummethosulfat available in a blend with Cetearylalkohle under the name Dehyquart® ^® F 75 miles.

The compounds containing alkyl groups used as surfactants may each be uniform substances. However, it is usually preferred to start with the production of these substances from native plant or animal raw materials, so that one Substance mixtures with different, depending on the particular raw material alkyl chain lengths obtained.

Other active ingredients, auxiliaries and additives are, for example

nonionic polymers such as vinyl pyrrolidone / vinyl acrylate copolymers, polyvinyl pyrrolidone and vinyl pyrrolidone / vinyl acetate copolymers and polysiloxanes, cationic polymers such as quaternized cellulose ethers, and other solid-stable compounds, zwitterionic and amphoteric polymers, which are stable or preferred as solids are available as commercial products, anionic polymers such as polyacrylic acids, crosslinked polyacrylic acids and vinyl acetate / crotonic acid copolymers, provided that they are stable or preferably commercially available as solids,

Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. For example, methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. Bentonite or fully synthetic hydrocolloids such as e.g. Polyvinyl alcohol, structurants such as glucose, maleic acid and lactic acid, hair conditioning compounds such as phospholipids, for example soya lecithin, egg lecithin and cephalins, and silicone oils

Protein hydrolysates, in particular elastin, collagen, keratin, milk protein, soy protein and wheat protein hydrolysates, their condensation products with fatty acids and quaternized protein hydrolysates, perfume oils, dimethyl isosorbide and cyclodextrins, dyes for coloring the preparations,

Active substances such as panthenol, pantothenic acid, allantoin, pyrrolidonecarboxylic acids and their salts,

Cholesterol,

Fats and waxes such as spermaceti, beeswax, montan wax, paraffins,

Fatty alcohols and fatty acid esters,

fatty acid,

Complexing agents such as EDTA, NTA and phosphonic acids, Swelling and penetration substances such as carbonates, bicarbonates, guanidines. Ureas and primary, secondary and tertiary phosphates,

The choice of these other substances will be made by those skilled in the art according to the desired properties of the agents.

In addition to the substances according to the invention, the agents according to the invention may contain one or more dye precursors.

Compositions according to the invention which additionally comprise at least one oxidation-type dye precursor of the developer type and / or optionally at least one coupler-type oxidation dye precursor are preferred.

With regard to the further dye precursors which can be used in the bleaching compositions according to the invention, the present invention is not subject to any restrictions. The bleaching agents according to the invention can be used as further dye precursors

Developer and / or coupler type oxidation dye precursors, and

Precursors of natural analog dyes, such as indole and indoline derivatives, and mixtures of representatives of these groups.

In a first preferred embodiment, the bleaching agent further contains at least one developer component. As developer components are usually primary aromatic amines with another, located in the para or ortho position, free or substituted hydroxy or amino group, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazole derivatives and 2,4,5,6-tetraaminopyrimidine and its derivatives used ,

It may be preferred according to the invention to use as the developer component a p-phenylenediamine derivative or one of its physiologically acceptable salts. Particular preference is given to p-phenylenediamine derivatives of the formula (E1)

in which G ¹ represents a hydrogen atom, a C ₁ - to C ₄ alkyl, C ₁ - to C ₄ - monohydroxyalkyl radical, a C ₂ - to C ₄ polyhydroxyalkyl radical, a (C ₁ - to C ₄ J-AIkOXy- ( C ₁ to C ₄ ) alkyl, a 4'-aminophenyl or C ₁ to C ₄ alkyl substituted with a nitrogen-containing group, a phenyl or a 4'-aminophenyl; G ² is a hydrogen atom a C ₁ - to C ₄ alkyl, C ₁ - to C ₄ - monohydroxyalkyl radical, a C ₂ - to C ₄ polyhydroxyalkyl radical, a (Ci to C ₄ J-AIkOXy- (C ₁ - to C ₄₎ alkyl radical or a C ₁ to C ₄ alkyl radical which is substituted by a nitrogen-containing group;

G ³ represents a hydrogen atom, a halogen atom such as a chlorine, bromine, iodine or fluorine atom, a Ci to C ₄ alkyl, C ₁ - to C ₄ monohydroxyalkyl radical, a C ₂ - to C ₄ - Polyhydroxyalkyl, C ₁ to C ₄ hydroxyalkoxy, C ₁ to C ₄ acetylaminoalkoxy, C ₁ to C ₄ mesylaminoalkoxy or C ₁ to C ₄ carbamoylaminoalkoxy;

G ⁴ represents a hydrogen atom, a halogen atom or a C ₁ - to C ₄ -alkyl radical or when G ³ and G ⁴ are ortho to each other, they may together form a bridging α, ω-alkylenedioxy group, such as, for example, an ethylenedioxy group.

Examples of the C ₁ - to C ₄ -alkyl radicals mentioned as substituents in the compounds according to the invention are the groups methyl, ethyl, propyl, isopropyl and butyl. Ethyl and methyl are preferred alkyl radicals. C ₁ -C ₄ -alkoxy radicals which are preferred according to the invention are, for example, a methoxy or an ethoxy group. Furthermore, as preferred examples of a C ₁ - to C ₄ -hydroxyalkyl group, a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group may be mentioned. A 2-hydroxyethyl group is particularly preferred. A particularly preferred C ₂ to C ₄ polyhydroxyalkyl group is the 1, 2-dihydroxyethyl group. Examples of halogen atoms are according to the invention F, Cl or Br atoms, Cl atoms are very particularly preferred. The other terms used are derived according to the invention from the definitions given here. Examples of nitrogen-containing groups of the formula (E1) are in particular the amino groups, C ₁ - to C ₄ -monoalkylamino groups, C ₁ - to C ₄ -dialkylamino groups, C ₁ - to C ₄ -trialkylammonium groups, C ₁ - to C ₄ - Monohydroxyalkylamino groups, imidazolinium and ammonium.

Particularly preferred p-phenylenediamines of the formula (E1) are selected from p-phenylenediamine, p-toluenediamine, 2-chloro-p-phenylenediamine, 2,3-dimethyl-p-phenylenediamine, 2,6-dimethyl-p-phenylenediamine, 2 , 6-diethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine, N, N-dipropyl-p-phenylenediamine, 4-amino 3-methyl- (N, N-diethyl) -aniline, N, N-bis- (β-hydroxyethyl) -p-phenylenediamine, 4-N, N-bis- (β-hydroxyethyl) amino-2-methylaniline, 4-N, N-bis- (β-hydroxyethyl) amino-2-chloroaniline, 2- (β- Hydroxyethyl) -p-phenylenediamine, 2- (α, β-dihydroxyethyl) -p-phenylenediamine, 2-fluoro-p-phenylenediamine, 2-isopropyl-p-phenylenediamine, N- (β-hydroxypropyl) -p-phenylenediamine, 2 - hydroxymethyl-p-phenylenediamine, N, N-dimethyl-3-methyl-p-phenylenediamine, N, N- (ethyl, .beta.-hydroxyethyl) -p-phenylenediamine, N- (.beta.,. Gamma.-dihydroxypropyl) -p phenylenediamine, N- (4'-aminophenyl) -p-phenylenediamine, N-phenyl-p-phenylenediamine, 2- (β-hydroxyethyloxy) -p-phenylenediamine, 2- (β-acetylaminoethyloxy) -p-phenylenediamine, N- (β-methoxyethyl) -p-phenylenediamine and 5,8-diaminobenzo-1, 4-dioxane and their physiologically acceptable salts.

Very particular preferred p-phenylenediamine derivatives of the formula (E1) according to the invention are p-phenylenediamine, p-toluenediamine, 2- (β-hydroxyethyl) -p-phenylenediamine, 2- (α, β-dihydroxyethyl) -p-phenylenediamine and N, N bis (.beta.-hydroxyethyl) -p-phenylenediamine.

It may further be preferred according to the invention to use as developer component compounds which contain at least two aromatic nuclei which are substituted by amino and / or hydroxyl groups.

Among the binuclear developer components which can be used in the compositions according to the invention, mention may be made in particular of the compounds which correspond to the following formula (E2) and their physiologically tolerated salts:

in which:

Z ¹ and Z ² independently of one another represent a hydroxyl or NH ₂ -ReSt which is optionally substituted by a C ₁ - to C ₄ -alkyl radical, by a C ₁ - to C ₄ -hydroxyalkyl radical and / or by a bond Y. or which is optionally part of a bridging ring system, the bridge Y is an alkylene group having 1 to 14 carbon atoms, such as a linear or branched alkylene chain or an alkylene ring, which is one or more nitrogen-containing groups and / or one or more heteroatoms such as oxygen , Sulfur or nitrogen atoms interrupted or terminated may be substituted by one or more hydroxyl or C _r to C ₈ -Al koxyreste, or a direct bond,

G ⁵ and G ⁶ are each independently a hydrogen or halogen atom, a Ci to C ₄ alkyl radical, a Ci to C ₄ monohydroxyalkyl radical, a C ₂ - to C ₄ -

Polyhydroxyalkyl radical, a C ₁ - to C ₄ -Aminoalkylrest or a direct connection to

Bridging Y,

G ⁷ , G ⁸ , G ⁹ , G ¹⁰ , G ¹¹ and G ¹² independently of one another represent a hydrogen atom, a direct bond to the bridge Y or a C _r to C ₄ -alkyl radical, with the provisos that the compounds of the formula ( E2) contain only one bridging Y per molecule and the compounds of the formula (E2) contain at least one amino group which carries at least one hydrogen atom.

The substituents used in formula (E2) are defined according to the invention analogously to the above statements.

Preferred binuclear developer components of the formula (E2) are in particular: N, N'-bis (β-hydroxyethyl) -N, N'-bis (4'-aminophenyl) -1,3-diamino-propan-2-ol, N, N'-bis (β-hydroxyethyl) -N, N'-bis (4'-aminophenyl) ethylenediamine, N, N'-bis (4-aminophenyl) tetramethylenediamine, N, N'-bis N, N'-bis (4-aminophenyl) tetramethylenediamine, N, N'-bis (4-methylaminophenyl) tetramethylenediamine, N, N'-diethyl-N, N ' bis (4'-amino-3'-methylphenyl) ethylenediamine, bis (2-hydroxy-5-aminophenyl) -methane, 1, 3-bis (2,5-diaminophenoxy) -propan-2-ol , N, N'-bis (4'-aminophenyl) -1, 4-diazacycloheptane, N, N'-bis (2-hydroxy-5-aminobenzyl) piperazine, N- (4'-aminophenyl) -p phenylenediamine and 1, 10-bis (2 ', 5'-diaminophenyl) -1, 4,7,10-tetraoxadecane and their physiologically acceptable salts.

Very particularly preferred binuclear developer components of the formula (E2) are N, N'-bis (β-hydroxyethyl) -N, N'-bis (4'-aminophenyl) -1,3-diamino-propan-2-ol, Bis (2-hydroxy-5-aminophenyl) methane, 1, 3-bis (2,5-diaminophenoxy) -propan-2-ol, N, N'-bis (4'-aminophenyl) -1, 4-diazacycloheptane and 1-amino-bis-1,3'-dibiaminophenyl O-1-A /.-O-tetraoxadecane or one of its physiologically acceptable salts.

Furthermore, it may be preferred according to the invention to use as the developer component a p-aminophenol derivative or one of its physiologically tolerable salts. Particular preference is given to p-aminophenol derivatives of the formula (E3)

in which:

G ¹³ represents a hydrogen atom, a halogen atom, a C ₁ - to C ₄ -alkyl radical, a C ₁ - to C ₄ -monohydroxyalkyl radical, a C ₂ - to C ₄ -polyhydroxyalkyl radical, a (C ₁ - to C ₄ , alkyl to C ₄₎ a C ₁ - -) alkoxy- (C ₁ -C ₄ aminoalkyl radical, a hydroxy ^ C ^ to C ₄₎ - alkylamino, C ₁ - to C ₄ -Hydroxyalkoxyrest, a Ci- to d-hydroxyalkyl ^ d to C ₄ ) aminoalkyl or a (di-C ₁ - to C ₄ alkylamino) - (C _r to C ₄ ) alkyl, and

G ¹⁴ represents a hydrogen or halogen atom, a C ₁ - to C ₄ alkyl, C ₁ - to C ₄ - monohydroxyalkyl radical, a C ₂ - to C ₄ polyhydroxyalkyl radical, a (C ₁ - to C ₄ J- AIkOXy- (C ₁ - to C ₄ ) -alkyl radical, a C ₁ - to C ₄ -Aminoalkylrest or a C ₁ - to C ₄ -Cyanoalkylrest,

G ¹⁵ is hydrogen, C ₁ - to C ₄ -alkyl, C ₁ - to C ₄ -monohydroxyalkyl, C ₂ - to C ₄ -polyhydroxyalkyl, phenyl or benzyl, and

G ¹⁶ is hydrogen or a halogen atom.

The substituents used in formula (E3) are defined according to the invention analogously to the above statements.

Preferred p-aminophenols of the formula (E3) are, in particular, p-aminophenol, N-methyl-p-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 2-hydroxymethylamino-4-aminophenol, 4 -Amino-3-hydroxymethylphenol, 4-amino-2- (β-hydroxyethoxy) -phenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethyl-phenol, 4-amino -2-aminomethylphenol, 4-amino-2- (β-hydroxyethyl-aminomethyl) phenol, 4-amino-2- (α, β-dihydroxyethyl) phenol, 4-amino-2-fluorophenol, 4-amino-2 -chlorophenol, 4-amino-2,6-dichlorophenol, 4-amino-2- (diethyl-aminomethyl) -phenol and their physiologically acceptable salts.

Very particularly preferred compounds of the formula (E3) are p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- (α, β-dihydroxyethyl) -phenol and 4-amino 2- (diethylaminomethyl) -phenol. Further, the developer component may be selected from o-aminophenol and its derivatives such as 2-amino-4-methylphenol, 2-amino-5-methylphenol or 2-amino-4-chlorophenol.

Further, the developer component may be selected from heterocyclic developer components, such as the pyridine, pyrimidine, pyrazole, pyrazole pyrimidine derivatives and their physiologically acceptable salts.

Preferred pyridine derivatives are in particular the compounds 2,5-diamino-pyridine, 2- (4'-methoxyphenyl) amino-3-amino-pyridine, 2,3-diamino-6-methoxypyridine, 2- (β-methoxyethyl ) amino-3-amino-6-methoxypyridine and 3,4-diamino-pyridine.

Preferred pyrimidine derivatives are in particular 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2-dimethylamino-4,5,6- triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6-triaminopyrimidine.

Preferred pyrazole derivatives are in particular 4,5-diamino-1-methylpyrazole, 4,5-diamino-1- (β-hydroxyethyl) pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1- (4'- chlorobenzyl) pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenylpyrazole, 4-amino -1, 3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert-butyl-1-methylpyrazole, 4,5-diamino-1 - tert-butyl-3-methylpyrazole, 4,5-diamino-1- (β-hydroxyethyl) -3-methylpyrazole, 4,5-diamino-1-ethyl-3-methylpyrazole, 4,5-diamino-1-ethyl -3- (4'-methoxyphenyl) pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethylpyrazole, 4,5-diamino-3-hydroxymethyl-1-methylpyrazole, 4,5-diamino-3-hydroxymethyl 1-isopropylpyrazole, 4,5-diamino-3-methyl-1-isopropylpyrazole, 4-amino-5- (β-aminoethyl) amino-1,3-dimethylpyrazole, 3,4,5-

Triaminopyrazole, 1-methyl-3,4,5-triaminopyrazole, 3,5-diamino-1-methyl-4-methylaminopyrazole and 3, 5-diamino-4- (β-hydroxyethyl) amino-1-methylpyrazole.

Preferred pyrazole-pyrimidine derivatives are, in particular, the derivatives of the pyrazolo [1,5-a] pyrimidine of the following formula (E4) and their tautomeric forms, if a tautomeric equilibrium exists:

G ¹⁷ , G ¹⁸ , G ¹⁹ and G ²⁰ independently of one another represent a hydrogen atom, a C ₁ - to C ₄ -alkyl radical, an aryl radical, a C ₁ - to C ₄ -hydroxyalkyl radical, a C ₂ - to C ₄ polyhydroxyalkyl a ₄ J-AIkOXy- -C (C ₁ - - C ₄₎ - (C -)! -a kylrest, a C ₁ - to C ₄ - aminoalkyl radical which is optionally substituted by an acetyl ureide or a sulfonyl Rest can be protected, a (C ₁ - to C ₄ ) alkylamino (C ₁ - to C ₄ ) alkyl, a DK (C ₁ - to C ₄ ) alkyl] - (Cr to C ₄ ) aminoalkyl where the dialkyl radicals optionally form a carbon cycle or a heterocycle having 5 or 6 chain members, a C ₁ - to C ₄ -hydroxyalkyl- or a di- (C ₁ - to C ₄ ) - [hydroxyalkyl] - (C ₁ - to C ₄ ) -aminoalkylrest, the X radicals independently of one another represent a hydrogen atom, a C ₁ - to C ₄ -alkyl radical, an aryl radical, a C ₁ - to C ₄ -hydroxyalkyl radical, a C ₂ - to C ₄ - polyhydroxyalkyl radical, a C ₁ - to C ₄ -aminoalkyl radical A (C ₁ - to C ₄₎ alkylamino (C ₁ - to C ₄₎ alkyl group a di - aminoalkyl group, wherein [(C _r to C ₄₎ alkyl] - - (C ₄ to C ₁₎ the dialkyl radicals optionally form a carbon cycle or a heterocycle having 5 or 6 chain members, a C ₁ - to C ₄ -hydroxyalkyl or a di- (C ₁ - to C ₄ -hydroxyalkyl) aminoalkyl radical, an amino radical, a d- to C ₄ alkyl or di (C 1 to C ₄ hydroxyalkyl) amino, a halogen atom, a carboxylic acid group or a sulfonic acid group, i has the value 0, 1, 2 or 3, p has the value 0 or 1, q has the value 0 or 1 and n has the value 0 or 1, with the proviso that the sum of p + q is not equal to 0, if p + q equals 2, n has the value 0, and the groups NG ¹⁷ G ¹⁸ and NG ¹⁹ G ²⁰ occupy the positions (2, 3); (5,6); (6,7); (3,5) or (3,7); when p + q is 1, n is 1, and the groups NG ¹⁷ G ¹⁸ (or NG ¹⁹ G ²⁰ ) and the group OH occupy the positions (2, 3); (5,6); (6,7); (3,5) or (3,7);

The substituents used in formula (E4) are defined according to the invention analogously to the above statements.

When the pyrazole [1,5-a] pyrimidine of the above formula (E4) contains a hydroxy group at one of the 2, 5 or 7 positions of the ring system, there is a tautomeric equilibrium shown, for example, in the following scheme:

Among the pyrazolo [1, 5-a] -pyrimidines of the above formula (E4) may be mentioned in particular:

Pyrazolo [1,5-a] pyrimidine-3,7-diamine;

2,5-dimethyl-pyrazolo [1,5-a] pyrimidine-3,7-diamine;

Pyrazolo [1,5-a] pyrimidine-3,5-diamine;

2,7-dimethyl-pyrazolo [1,5-a] -pyrimidine-3,5-diamine;

3-aminopyrazolo [1,5-a] pyrimidin-7-ol;

3-aminopyrazolo [1,5-a] pyrimidin-5-ol;

2- (3-aminopyrazolo [1,5-a] pyrimidin-7-ylamino) ethanol;

2- (7-aminopyrazolo [1,5-a] pyrimidin-3-ylamino) ethanol;

2 - [(3-aminopyrazolo [1,5-a] pyrimidin-7-yl) (2-hydroxyethyl) amino] ethanol;

2 - [(7-aminopyrazolo [1,5-a] pyrimidin-3-yl) - (2-hydroxy-ethyl) amino] -ethanol;

5,6-dimethylpyrazolo [1,5-a] pyrimidine-3,7-diamine;

2,6-dimethylpyrazolo [1,5-a] pyrimidine-3,7-diamine;

S-amino-dimethyl-amino-α, δ-dimethylpyrazole-1-δ-α-pyrimidine; and their physiologically acceptable salts and their tautomeric forms when tautomeric equilibrium is present.

The pyrazolo [1, 5-a] -pyrimidines of the above formula (E4) can be prepared as described in the literature by cyclization from an aminopyrazole or from hydrazine.

In a further preferred embodiment, the agents according to the invention contain at least one coupler component.

As coupler components m-phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are generally used. Suitable coupler substances are in particular 1-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinol monomethyl ether, m-phenylenediamine, 1-phenyl 3-methyl-pyrazolone-5, 2,4-dichloro-3-aminophenol, 1, 3-bis (2 ', 4'-diaminophenoxy) -propane, 2- Chloro-resorcinol, 4-chloro-resorcinol, 2-chloro-6-methyl-3-aminophenol, 2-amino-3-hydroxypyridine, 2-methylresorcinol, 5-methylresorcinol and 2-methyl-4-chloro-5-aminophenol.

Coupler components preferred according to the invention are m-aminophenol and its derivatives, such as, for example, 5-amino-2-methylphenol, N-

Cyclopentyl-3-aminophenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 2,6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5- Amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5- (2'-

Hydroxyethyl) amino-2-methylphenol, 3- (diethylamino) phenol, N-cyclopentyl-3-aminophenol,

1, 3-Dihydroxy-5- (methylamino) benzene, 3-ethylamino-4-methylphenol and 2,4-dichloro-3-aminophenol, o-aminophenol and its derivatives, m-diaminobenzene and its derivatives such as 2,4 -Diaminophenoxyethanol, 1, 3

Bis- (2 ', 4'-diaminophenoxy) -propane, 1-methoxy-2-amino-4- (2'-hydroxyethylamino) benzene, 1, 3

Bis (2 ', 4'-diaminophenyl) propane, 2,6-bis (2'-hydroxyethylamino) -1-methylbenzene and 1-bis

Amino-3-bis (2'-hydroxyethyl) aminobenzene, o-diaminobenzene and its derivatives such as 3,4-diaminobenzoic acid and 2,3-

Diamino-1-methylbenzene,

Di- or trihydroxybenzene derivatives such as resorcinol,

Resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-

Chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1,2,4-trihydroxybenzene,

Pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino

5-chloro-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy-3,4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2, 3-diamino-6-methoxypyridine and 3,5-diamino-2,6-dimethoxypyridine,

Naphthalene derivatives such as 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1, 5-dihydroxynaphthalene, 1, 6-dihydroxynaphthalene, 1, 7

Dihydroxynaphthalene, 1,8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-

dihydroxynaphthalene,

Morpholine derivatives such as 6-hydroxybenzomorpholine and 6-aminobenzomorpholine,

Quinoxaline derivatives such as 6-methyl-1,2,3,4-tetrahydroquinoxaline,

Pyrazole derivatives such as 1-phenyl-3-methylpyrazol-5-one,

Indole derivatives such as 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole,

Pyrimidine derivatives such as 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine,

2,4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2-amino-4-methylpyrimidine, 2-

Amino-4-hydroxy-6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine, or Methylenedioxybenzene derivatives such as 1-hydroxy-3,4-methylenedioxybenzene, 1-amino-3,4-methylenedioxybenzene and 1- (2'-hydroxyethyl) amino-3,4-methylenedioxybenzene.

Particularly preferred coupler components according to the invention are 1-naphthol, 1, 5, 2,7- and 1, 7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol , 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.

As precursors of naturally-analogous dyes such indoles and indolines are preferably used which have at least one hydroxy or amino group, preferably as a substituent on the six-membered ring. These groups may carry further substituents, e.g. Example in the form of etherification or esterification of the hydroxy group or alkylation of the amino group. In a second preferred embodiment, the agents contain at least one indole and / or indoline derivative.

Particularly suitable precursors of naturally-analogous hair dyes are derivatives of 5,6-dihydroxyindoline of the formula (IIIa),

R ¹ (purple) in the independently

R ¹ is hydrogen, a C ¹ -C ₄ -alkyl group or a C ¹ -C 8 -hydroxyalkyl group,

R ² is hydrogen or a -COOH group, wherein the -COOH group may also be present as a salt with a physiologically compatible cation,

R ³ is hydrogen or a C 1 -C 4 alkyl group,

R ⁴ is hydrogen, a C 1 -C ₄ -alkyl group or a group -CO-R ⁶ , in which R ⁶ is a C 1 -C ₄ -alkyl group, and

R ⁵ is one of the groups mentioned under R ⁴ , as well as physiologically acceptable salts of these compounds with an organic or inorganic acid.

Particularly preferred derivatives of indoline are 5,6-dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline,

N-butyl-5,6-dihydroxyindoline, 5,6-dihydroxyindoline-2-carboxylic acid and 6-hydroxyindoline, 6-aminoindoline and 4-aminoindoline. Particularly noteworthy within this group are N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and especially 5, 6-Dihydroxyindolin.

Also suitable as precursors of naturally-analogous hair dyes are derivatives of the 5,6-dihydroxyindole of the formula (NIb),

in the independently of each other

R ¹ is hydrogen, a C ¹ -C ₄ -alkyl group or a C ¹ -C ₄ -hydroxyalkyl group,

R ³ is hydrogen or a CτC ₄ -alkyl group,

R ⁴ is hydrogen, a C ₁ -C ₄ -alkyl group or a group -CO-R ⁶ , in which R ⁶ is a C ₁ -C ₄ -alkyl group, and

Particularly preferred derivatives of indole are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6- dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, 6-hydroxyindole, 6-aminoindole and 4-aminoindole.

Emphasized within this group are N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, and especially the 5,6 -Dihydroxyindol.

The indoline and indole derivatives can be used in the agents used in the process according to the invention both as free bases and in the form of their physiologically acceptable salts with inorganic or organic acids, eg. As the hydrochlorides, the sulfates and Hydrobromide used. The indole or indoline derivatives are contained therein usually in amounts of 0.05-10 wt .-%, preferably 0.2-5 wt .-%. In a further embodiment, it may be preferred according to the invention to use the indoline or indole derivative in hair dyes in combination with at least one amino acid or an oligopeptide. The amino acid is advantageously an α-amino acid; Very particularly preferred α-amino acids are arginine, ornithine, lysine, serine and histidine, in particular arginine.

Preferred agents according to the invention are characterized in that they contain at least one dye precursor from the groups of aromatic and heteroaromatic diamines, aminophenols, naphthols, polyphenols CH-acidic coupler components and their derivatives in amounts of from 0.01 to 25% by weight, preferably 0.5 to 10 wt.%, In particular from 1 to 5 wt .-%, each based on the total agent included.

In addition to the substances according to the invention, the compositions according to the invention for shading may contain one or more substantive dyes.

Direct dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols. Preferred substantive dyes are those having the international designations or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange 1, Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red

11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue

12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, and Acid Black 52 known compounds as well as 1, 4-Diamino 2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis (β-hydroxyethyl) amino-2-nitrobenzene, 3-nitro-4- (β-hydroxyethyl) aminophenol, 2- (2'-hydroxyethyl ) amino-4,6-dinitrophenol, 1- (2'-hydroxyethyl) amino-4-methyl-2-nitrobenzene, 1-amino-4- (2'-hydroxyethyl) amino-5-chloro-2-nitrobenzene, 4 Amino-3-nitrophenol, 1- (2'-ureidoethyl) amino-4-nitrobenzene, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, 2-hydroxy-1,4-naphthoquinone, picramic acid and its salts, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1-hydroxy-4-nitrobenzene ,

Corresponding agents according to the invention, which are characterized in that they contain at least one substantive dye from the group of cationic (basic) dyes, preferably Basic Blue 6, CI-No. 51, 175; Basic Blue 7, CI -No. 42.595; Basic Blue 9, Cl-No. 52.015; Basic Blue 26, Cl-No. 44.045; Basic Blue 41, Cl-No. 11, 154; Basic Blue 99, Cl-No. 56.059; Basic Brown 4, Cl-No. 21, 010; Basic Brown 16, Cl-No. 12.250; Basic Brown 17, Cl- No. 12,251; Basic Green 1, Cl-No. 42.040; Basic Orange 31; Basic Red 2, Cl-No. 50.240; Basic Red 22, Cl-No. 11, 055; Basic Red 46; Basic Red 51; Basic Red 76, Cl-No. 12.245; basic Violet 1, Cl-No. 42.535; Basic Violet 2; Basic Violet 3, Cl-No. 42.555; Basic Violet 10, Cl-No. 45.170; Basic Violet 14, Cl-No. 42.510; Basic Yellow 57, Cl-No. 12.719; Basic Yellow 87 and / or the anionic (acidic) dyes, and / or the nonionic dyes, preferably Acid Black 1, Cl-No. 20.470; Acid Black 52; Acid Blue 7; Acid Blue 9, Cl-No. 42.090; Acid Blue 74, Cl-No. 73.015, Acid Red 18, Cl-No. 16.255; Acid Red 23; Acid Red 27, Cl-No. 16.185; Acid Red 33; Acid Red 52; Acid Red 87, Cl-No. 45,380; Acid Red 92, Cl-No. 45,410; Acid Orange 3; Acid Orange 7; Acid Violet 43, Cl-No. 60.730; Acid Yellow 1, Cl-No. 10.316; Acid Yellow 10; Acid Yellow 23, Cl-No. 19,140; Acid Yellow 3, Cl-No. 47.005; Acid Yellow 36; D & C Brown no. 1, Cl-No. 20.170 (Acid Orange 24); D & C Green no. 5, Cl-No. 61, 570 (Acid Green G); D & C Orange No. 4, Cl-No. 15.510 (Acid Orange II); D & C Orange No. 10, CI-No. 45.425: 1 (Solvent Red 73); D & C Orange No. 11, Cl-No. 45.425 (Acid Red 95); D & C Red No. 21, Cl-No. 45.380: 2 (Solvent Red 43); D & C Red No. 27, Cl-No. 45.410: 1 (Solvent Red 48); D & C Red No. 33, Cl-No. 17,200 (Acid Red 2A, Acid Red B); D & C Yellow No. 7, CI-No. 45.350: 1 (Solvent Yellow 94); D & C Yellow No. 8, Cl-No. 45,350 (Acid Yellow 73); FD & C Red No. 4, Cl-No. 14,700 (Food Red 4); FD & C Yellow No. 6, Cl-No. 15,985 (Food Yellow 3); Food Green 3; Pigment Red 57-1; Disperse Black 9; Disperse Blue 1; Disperse Blue 3; Disperse Violet 1; Disperse Violet 4; HC Orange 1; HC Red 1; HC Red 3; HC Red 13; HC Yellow 2; HC Yellow 4; Na-Pikramat; 1, 4-bis (2 ^{'-hydroxyethyl)} amino-2-nitro-p-phenylenediamine; HC Yellow 5; HC Blue 2; HC Blue 12; 4-amino-3-nitrophenol; HC Yellow 6; HC Yellow 12; 2-Nitro-1- (2 ^{'hydroxyethyl)} amino-4-methyl benzene; 2-nitro-4-amino-diphenylamine-2-carboxylic acid; 2-amino-6-chloro-4-nitrophenol; HC Red BN; 6-nitro-1,2,3,4-tetranitroquinoxaline; o-nitro-p-phenylenediamine; p-nitro-m-phenylenediamine; HC Red B 54; HC Red 10; HC Red 11; HC Red 13; 2- (2 ^'- hydroxyethyl) amino-1-hydroxy-4,6-dinitrobenzene; 4-ethylamino-3-nitrobenzoic acid; 2-chloro-6-ethylamino-4-nitrophenol; 2-hydroxy-1,4-naphthoquinone; 1-propene (4-amino-2-nitrophenyl) amine; isatin; N-methylylisatin; HC Violet 1; HC Violet 2; 4-Nitrophenyl-aminoethyl urea in amounts of 0.01 to 25 wt.%, Preferably from 0.5 to 10 wt.%, In particular from 1 to 5 wt .-%, each based on the total agent included, are preferred embodiments of the present invention.

Among the above-mentioned dyes, some representatives are particularly preferred, for which reason further preferred agents according to the invention are characterized in that they comprise at least one direct-puller selected from Basic Blue 7, Basic Blue 99, Basic Violet 14, Basic Brown 16, Basic Brown 17, Basic Orange 31, Basic Red 46, Basic Red 51, Basic Red 76, Basic Yellow 57, Basic Yellow 87, Acid Black 1, Acid Blue 7, Acid Violet 43, Acid Red 23, Acid Red 52, Acid Orange 7, Acid Yellow Disperse Blue 1, Disperse Blue 3, Disperse Violet 1, Disperse Violet 4, HC Orange 1, HC Red 1, HC Red 1, Acid Yellow 10, Acid Yellow 36, Food Green 3, Pigment Red 57-1, Disperse Black 9, Disperse Blue 1 3, HC Red 13, HC Yellow 2, HC Yellow 4, Na Pikramat, 1, 4- Bis (2 ^{'-hydroxyethyl)} amino-2-nitro-p-phenylenediamine, HC Yellow 5, HC Blue 2, HC Blue 12, 4-amino-3-nitrophenol, HC Yellow 6, HC Yellow 12, 2-nitro 1- (2 ^{'hydroxyethyl)} amino-4-methyl benzene, 2-nitro-4-amino-diphenylamine-2-carboxylic acid, 2-amino-6-chloro-4-nitrophenol, HC Red BN; 6-nitro-1,2,3,4-tetranitroquinoxaline, o-nitro-p-phenylenediamine, p-nitro-m-phenylenediamine, HC Red B 54, HC Red 10, HC Red 11, HC Red 13, 2- 2 ^{'-hydroxyethyl)} amino-1-hydroxy-4,6-dinitrobenzene, 4-ethylamino-3-nitrobenzoic acid, 2-chloro-6-ethylamino-4-nitrophenol, 2-hydroxy-1, 4-naphthoquinone, 1-propene - (4-amino-2-nitrophenyl) amine, isatin, N-Methylylisatin, HC Violet 1, HC Violet 2, 4-nitrophenyl-aminoethyl urea in amounts of 0.01 to 25 wt.%, Preferably from 0.5 to 10 % By weight, in particular from 1 to 5% by weight, in each case based on the total agent, are preferred.

Furthermore, the agents according to the invention may contain a cationic substantive dye. Particularly preferred are

(a) cationic triphenylmethane dyes such as Basic Blue 7, Basic Blue 26, Basic Violet 2 and Basic Violet 14,

(b) aromatic systems substituted with a quaternary nitrogen group, such as Basic Yellow 57, Basic Red 76, Basic Blue 99, Basic Brown 16 and Basic Brown 17, as well as

(c) substantive dyes containing a heterocycle having at least one quaternary nitrogen atom, as mentioned, for example, in EP-A2-998 908, which is incorporated herein by reference, in claims 6 to 11.

Preferred cationic substantive dyes of group (c) are in particular the following compounds:

CH ₃ SO ₄ ^"

he

The compounds of the formulas (DZ1), (DZ3) and (DZ5), which are also known by the names Basic Yellow 87, Basic Orange 31 and Basic Red 51, are very particularly preferred cationic substantive dyes of group (c).

The cationic direct dyes, which are sold under the trademark Arianor ^® are, according to the invention also very particularly preferred cationic direct dyes.

The agents according to the invention according to this embodiment preferably contain the substantive dyes in an amount of 0.01 to 20 wt .-%, based on the total agent.

Furthermore, the preparations of the invention may also naturally occurring dyes such as henna red, henna neutral, henna black, chamomile, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, Catechu, Sedre and alkano root are included. It is not necessary for the oxidation dye precursors or the direct dyes to be in each case homogeneous compounds. Rather, in the inventive compositions, due to the production process for the individual dyes, in minor amounts, other components may be included, as far as they do not adversely affect the staining or other reasons, such as toxicological, must be excluded.

With regard to the dyes which can be used in the hair-dyeing and tinting compositions according to the invention, reference is expressly made to the monograph Ch. Zviak, The Science of Hair Care, Chapter 7 (pages 248-250, direct dyes) and Chapter 8, pages 264-267; Oxidation dye precursors), published as Volume 7 of the series "Dermatology" (Editor: Ch., Culnan and H. Maibach), published by Marcel Dekker Inc., New York, Basel, 1986, and the "European Inventory of Cosmetic Raw Materials", Issued by the European Community, available in disk form from the Federal Association of German industrial and commercial enterprises for pharmaceuticals, health products and personal care registered association, Mannheim, reference is made.

In a further embodiment, the agent according to the invention additionally contains a

Combination of component

A compounds containing a reactive carbonyl group with component

B Compounds selected from (a) CH-acidic compounds, (b) compounds having primary or secondary amino group or hydroxy group selected from primary or secondary aromatic amines, nitrogen-containing heterocyclic compounds and aromatic hydroxy compounds, (c) amino acids, (d) from 2 up to 9 amino acids oligopeptides.

Compounds according to the invention having a reactive carbonyl group (also referred to below as reactive carbonyl compounds or component A) have at least one carbonyl group as reactive group which reacts with the compounds of component B to form a chemical bond linking both components. Furthermore, those compounds according to the invention are also included as component A in which the reactive carbonyl group is derivatized or masked in such a way that the reactivity of the carbon atom of the derivatized or masked carbonyl group with respect to component B is always present. These derivatives are preferably condensation compounds of reactive carbonyl compounds with a) amines and their derivatives to form imines or oximes as a condensation compound b) of alcohols to form acetals or ketals as a condensation compound.

Component A is preferably selected from the group formed from acetophenone, propiophenone, 2-hydroxyacetophenone, 3-hydroxyacetophenone, 4-hydroxyacetophenone, 2-hydroxypropiophenone, 3-hydroxypropiophenone, 4-hydroxypropiophenone, 2-hydroxybutyrophenone, 3 Hydroxybutyrophenone, 4-hydroxybutyrophenone, 2,4-dihydroxyacetophenone, 2,5-dihydroxyacetophenone, 2,6-dihydroxyacetophenone, 2,3,4-trihydroxyacetophenone, 3,4,5-trihydroxyacetophenone, 2,4,6-dihydroxyacetophenone Trihydroxyacetophenone, 2,4,6-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone diethyl ketal, 4-hydroxy-3-methoxy-acetophenone, 3,5-dimethoxy-4- hydroxyacetophenone, 4-aminoacetophenone, 4-dimethylaminoacetophenone, 4-morpholinoacetophenone, 4-piperidinoacetophenone, 4-imidazolinoacetophenone, 2-hydroxy-5-bromo-acetophenone, 4-hydroxy-3-nitroacetophenone, acetophenone-2-carboxylic acid, acetophenone-4 carboxylic acid, benzophenone, 4-

Hydroxybenzophenone, 2-aminobenzophenone, 4,4'-dihydroxybenzophenone, 2,4-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone, 2,3,4-trihydroxybenzophenone, 2-hydroxy-1-acetonaphthone, 1-hydroxybenzophenone 2-acetonaphthone, chromone, chromone-2-carboxylic acid, flavone, 3-hydroxyflavone, 3,5,7-trihydroxyflavone, 4 ', 5,7-trihydroxyflavone, 5,6,7-trihydroxyflavone, quercetin, 1-indanone, 9 Fluorenone, 3-hydroxyfluorenone, anthrone, 1,8-dihydroxyanthrone, vanillin, coniferylaldehyde, 2-methoxybenzaldehyde, 3-methoxybenzaldehyde, 4-methoxybenzaldehyde, 2-ethoxybenzaldehyde, 3-ethoxybenzaldehyde, 4-ethoxybenzaldehyde, 4-hydroxy-2,3 dimethoxybenzaldehyde, 4-hydroxy-2,5-dimethoxybenzaldehyde, 4-hydroxy-2,6-dimethoxybenzaldehyde, 4-hydroxy-2-methylbenzaldehyde, 4-hydroxy-3-methylbenzaldehyde, 4 Hydroxy-2,3-dimethylbenzaldehyde, 4-hydroxy-2,5-dimethylbenzaldehyde, 4-hydroxy-2,6-dimethylbenzaldehyde, 4-hydroxy-3,5-dimethoxybenzaldehyde, 4-hydroxy -3,5-dimethylbenzaldehyde, 3,5-diethoxy-4-hydroxy-benzaldehyde, 2,6-diethoxy-4-hy hydroxy-benzaldehyde, 3-hydroxy-4-methoxybenzaldehyde, 2-hydroxy-4-methoxybenzaldehyde, 2-ethoxy-4-hydroxybenzaldehyde, 3-ethoxy-4-hydroxybenzaldehyde, 4-ethoxy-2-one hydroxybenzaldehyde, 4-ethoxy-3-hydroxybenzaldehyde, 2,3-dimethoxybenzaldehyde, 2,4-dimethoxybenzaldehyde, 2,5-dimethoxybenzaldehyde, 2,6-dimethoxybenzaldehyde, 3,4-dimethoxybenzaldehyde, 3,5-dimethoxybenzaldehyde, 2,3,4-trimethoxybenzaldehyde, 2,3,5-trimethoxybenzaldehyde, 2,3,6-trimethoxybenzaldehyde, 2,4,6-trimethoxybenzaldehyde, 2,4,5-trimethoxybenzaldehyde, 2,5,6-trimethoxybenzaldehyde, 2- Hydroxybenzaldehyde, 3-hydroxybenzaldehyde, 4-hydroxybenzaldehyde, 2,3-dihydroxybenzaldehyde, 2,4-dihydroxybenzaldehyde, 2,5-dihydroxybenzaldehyde, 2,6-dihydroxybenzaldehyde, 3,4-dihydroxybenzaldehyde, 3,5-dihydroxybenzaldehyde, 2,3, 4-trihydroxybenzaldehyde, 2,3,5-trihydroxybenzaldehyde, 2,3,6-trihydroxybenzaldehyde, 2,4,6-trihydroxybenzaldehyde, 2,4,5-trihydroxybenzaldehyde, 2,5,6-trihydroxybenzaldehyde, 4-hydroxy-2- methoxybenzaldehyde, 4-dimethylaminoben zaldehyde, 4-diethylaminobenzaldehyde, 4- Dimethylamino-2-hydroxybenzaldehyde, 4-diethylamino-2-hydroxybenzaldehyde, 4-pyrrolidino-dendinaldehyde, 4-morpholinobenzaldehyde, 2-morpholinobenzaldehyde, 4-piperidinobenzaldehyde, 2-methoxy-1-naphthaldehyde, 4-methoxy-1-naphthaldehyde, 2- Hydroxy-1-naphthaldehyde, 2,4-dihydroxy-1-naphthaldehyde, 4-hydroxy-3-methoxy-1-naphthaldehyde, 2-hydroxy-4-methoxy-1-naphthaldehyde, 3-hydroxy-4-methoxy-1 - naphthaldehyde, 2,4-dimethoxy-1-naphthaldehyde, 3,4-dimethoxy-1-naphthaldehyde, 4-hydroxy-1-naphthaldehyde, 4-dimethylamino-1-naphthaldehyde, 2-methoxycinnamaldehyde, 4-methoxycinnamaldehyde, 4-hydroxy-3-methoxycinnamaldehyde, 3,5-dimethoxy-4-hydroxy-cinnamaldehyde, 4-dimethylaminocinnamaldehyde, 2-dimethylaminobenzaldehyde, 2-chloro-4-dimethylaminobenzaldehyde, 4-dimethylamino-2-methylbenzaldehyde, 4-diethylamino cinnamic aldehyde, 4-dibutylaminobenzaldehyde, 4-diphenylaminobenzaldehyde, 4-dimethylamino-2-methoxybenzaldehyde, 4- (1-imidazolyl) benzaldehyde, piperonal, 2,3,6,7-tetrahydro-1H, 5H-benzo [ij] quinolizine-9-carboxy aldehyde, 2,3 _l 6,7-tetrahydro-8-hydroxy-1 H, 5H-benzo [ij] quinolizine-9-carboxaldehyde, N-ethylcarbazole-3-aldehyde 2-formylmethylene-1, 3,3-trimethylindolin (Fischer's aldehyde or tribasic aldehyde),

2-indolaldehyde, 3-indolaldehyde, 1-methylindole-3-aldehyde, 2-methylindole-3-aldehyde, 1-acetylindole-3-aldehyde, 3-acetylindole, 1-methyl-3-acetylindole, 2- (1 ', 3 ¹ , 3'-trimethyl-2-indolinylidene) -acetaldehyde, 1-methylpyrrole-2-aldehyde, 1-methyl-2-acetylpyrrole, 4-pyridine aldehyde, 2-pyridine aldehyde, 3-pyridine aldehyde, 4-acetylpyridine, 2-acetylpyridine , 3-acetylpyridine, pyridoxal, quinoline-3-aldehyde, quinoline-4-aldehyde, antipyrin-4-aldehyde, furfural, 5-nitrofurfural, 2-thenoyl-trifluoro-acetone, chromon-3-aldehyde, 3- (5 'Nitro-2'-furyl) acrolein, 3- (2'-furyl) acrolein and imidazole-2-aldehyde, 1, 3-diacetylbenzene, 1,4-diacetylbenzene, 1,3,5-triacetylbenzene, 2- Benzoyl-acetophenone, 2- (4'-methoxybenzoyl) -acetophenone, 2- (2'-furoyl) -acetophenone, 2- (2'-pyridoyl) -acetophenone and 2- (3'-pyridoyl) -acetophenone,

Benzylideneacetone, 4-hydroxybenzylideneacetone, 2-hydroxybenzylideneacetone, 4-methoxybenzylideneacetone, 4-hydroxy-3-methoxybenzylideneacetone, 4-dimethylaminobenzylideneacetone, 3,4-methylenedioxybenzylideneacetone, 4-pyrrolidinobenzylideneacetone, 4-piperidinobenzylideneacetone, 4-morpholinobenzylideneacetone, 4- Diethylaminobenzylideneacetone, 3-benzylidene-2,4-pentanedione, 3- (4'-hydroxybenzylidene) -2,4-pentanedione, 3- (4'-dimethylaminobenzylidene) -2,4-pentanedione, 2-benzylidenecyclohexanone, 2- (4 '-Hydroxybenzylidene) cyclohexanone, 2- (4'-dimethylaminobenzylidene) cyclohexanone, 2-benzylidene-1, 3-cyclohexanedione, 2- (4'-hydroxybenzylidene) -1,3-cyclohexanedione, 3- ( 4'-dimethylaminobenzylidene) -1, 3-cyclohexanedione, 2-benzylidene-5,5-dimethyl-1,3-cyclohexanedione, 2- (4'-hydroxybenzylidene) -5,5-dimethyl-1,3-cyclohexanedione, 2 - (4'-hydroxy-3-methoxybenzylidene) -5,5-dimethyl-1,3-cyclohexanedione, 2- (4'-dimethylaminobenzylidene) -5,5-dimethyl-1,3-cyclohexanedione, 2-benzylidenecyclopentanone , 2 '- (4-hydroxybenzylidene) -cyclopene tanon, 2- (4'-dimethylaminobenzylidene) cyclopentanone,

5- (4-dimethylaminophenyl) penta-2,4-dienal, 5- (4-diethylaminophenyl) penta-2,4-dienal, 5- (4-methoxyphenyl) penta-2,4-dienal, 5- (3, 4-dimethoxyphenyl) penta-2,4-dienal, 5- (2,4-dimethoxy- phenyl) penta-2,4-dienal, 5- (4-piperidinophenyl) penta-2,4-dienal, 5- (4-morpholinophenyl) penta-2,4-dienal, 5- (4-pyrrolidinophenyl) penta-2 , 4-dienal,

6- (4-dimethylaminophenyl) hexa-3,5-dien-2-one _l 6- (4-diethylaminophenyl) hexa-3,5-dien-2-one, 6- (4-methoxyphenyl) hexa-3,5 -dien-2-one, 6- (3,4-dimethoxyphenyl) hexa-3,5-dien-2-one, 6- (2,4-dimethoxyphenyl) hexa-3,5-dien-2-one , 6- (4-Piperidinophenyl) hexa-3,5-dien-2-one, 6- (4-morpholinophenyl) -hexa-3,5-dien-2-one, 6- (4-pyrrolidinophenyl) hexa-3 , 5-diene-2-one,

5- (4-Dimethylamino-1-naphthyl) penta-3,5-dienal, 2-nitrobenzaldehyde, 3-nitrobenzaldehyde, 4-nitrobenzaldehyde, 4-methyl-3-nitrobenzaldehyde, 3-hydroxy-4-nitrobenzaldehyde, 4-hydroxy -3-nitrobenzaldehyde, 5-hydroxy-2-nitrobenzaldehyde, 2-hydroxy-5-nitrobenzaldehyde, 2-hydroxy-3-nitrobenzaldehyde, 2-fluoro-3-nitrobenzaldehyde, 3-methoxy-2-nitrobenzaldehyde, 4-chloro-3 nitrobenzaldehyde, 2-chloro-6-nitrobenzaldehyde, 5-chloro-2-nitrobenzaldehyde, 4-chloro-2-nitrobenzaldehyde, 2,4-dinitrobenzaldehyde, 2,6-dinitrobenzaldehyde, 2-hydroxy-3-methoxy-5-nitrobenzaldehyde , 4,5-dimethoxy-2-nitrobenzaldehyde, 6-nitropiperonal, 2-nitropiperonal, 5-nitrovanillin, 2,5-dinitrosalicylaldehyde, 5-bromo-3-nitrosalicylaldehyde, 3-nitro-4-formylbenzenesulfonic acid, 4-nitro 1-naphthaldehyde, 2-nitrocinnamaldehyde, 3-nitrocinnamaldehyde, 4-nitrocinnamaldehyde, 9-methyl-3-carbazolaldehyde, 9-ethyl-3-carbazolaldehyde, 3-acetylcarbazole, 3,6-diacetyl-9-ethylcarbazole, 3-acetyl -9-methylcarbazole, 1, 4-dimethyl-3-carbazolaldehyde, 1, 4,9-trimethyl l-3-carbazolaldehyd,

4-formyl-1-methylpyridinium, 2-formyl-1-methylpyridinium, 4-formyl-1-ethylpyridinium, 2-formyl-1-ethylpyridinium, 4-formyl-1-benzylpyridinium, 2-formyl-1 benzylpyridinium, 4-formyl-1,2-dimethylpyridinium, 4-formyl-1,3-dimethylpyridinium, 4-formyl-1-methylquinolinium, 2-formyl-1-methylquinolinium, 4-acetyl-1 methylpyridinium, 2-acetyl-1-methylpyridinium, 4-acetyl-1-methylquinolinium, 5-formyl-1-methylquinolinium, 6-formyl-1-methylquinolinium, 7-formyl-1-methylquinolinium, 8- Formyl-i-methylquinolinium, 5-formyl-i-ethylquinolinium, 6-formyl-1-ethylquinolinium, 7-formyl-1-ethylquinolinium, 8-formyl-1-ethylquinolinium, 5-formyl-1-benzylchinolinium, 6-Formyl-1-benzyl-quinolinium, 7-formyl-1-benzyl-quinolinium, 8-formyl-1-benzyl-quinolinium, 5-formyl-1-allyl-quinolinium, 6-formyl-1-allyl-quinolinium, 7-formyl-1 allyl-quinolinium and 8-formyl-i-allyl-quinolinium, δ-acetyl-1-methyl-quinolinium, 6-acetyl-1-methyl-quinolinium, 7-acetyl-1-methyl-quinolinium, 8-acetyl-1-methylquinolinium, 5-acetyl-1-ethylquinolinium, 6-acetyl-1-ethylquinolinium, 7-acetyl-1-ethylquinolinium, 8-acetyl-1-ethylquinolinium, 5-acetyl-1-benzylquinolinium , 6-acetyl-1-benzyl-quinolinium, 7-acetyl-1-benzyl-quinolinium, 8-acetyl-1-benzyl-quinolinium, 5-acetyl-1-allyl-quinolinium, 6-acetyl-1-allyl-quinolinium, 7-acetyl 1-allylchinolinium- and 8-acetyl-1-allylchinolinium, 9-formyl-10-methyl-acridinium, 4- (2 ^l -Formylvinyl) -1-methylpyridinium, 1, 3-dimethyl-2- (4'- formylphenyl) benzimidazolium, 1,3-dimethyl-2- (4'-formylphenyl) imidazolium, 2- (4'-formylphenyl) -3-methylbenzothiazolium, 2- (4'-acetylphenyl) 3-methylbenzothiazolium, 2- (4'-formylphenyl) -3-methylbenzoxazolium, 2- (5'-formyl-2'-furyl) -3-methylbenzothiazolium, 2- (5'-formyl-2 '-furyl) -3- methylbenzothiazolium, 2- (5'-formyl-2'-thienyl) -3-methylbenzothiazolium, 2- (3'-formylphenyl) -3-methylbenzothiazolium, 2- (4'-formyl-1-naphthyl) -3 methylbenzothiazolium, 5-chloro-2- (4'-formylphenyl) -3-methylbenzothiazolium, 2- (4'-formylphenyl) -3,5-dimethylbenzothiazolium benzenesulfonate, p-toluenesulfonate, methanesulfonate, perchlorate, sulfate, chloride, bromide, iodide, tetrachlorozincate, methylsulfate, trifluoromethanesulfonate, tetrafluoroborate, isatin, 1-methylisatin, 1-allyl-isatin, 1-hydroxymethyl-isatin, 5-chloro-isatin, 5-methoxy-isatin, 5-nitro-isatin, 6-nitro-isatin, 5-sulfo-isatin, 5-carboxy-isatin, quinisatin, 1-methyl-quinisatin, and any mixtures of the above compounds.

As CH-acidic compounds are generally considered to carry a bound to an aliphatic carbon atom hydrogen atom, wherein due to electron-withdrawing substituents activation of the corresponding carbon-hydrogen bond is effected. According to the invention, CH-acidic compounds also include enamines which are formed by alkaline treatment of quaternized N-heterocycles with a CH-acidic alkyl group in conjugation with the quaternary nitrogen.

The CH-acidic compounds of component B are preferably selected from the group consisting of 1, 2,3,3-tetramethyl-3H-indolium iodide, 1, 2,3,3-tetramethyl-3H-indolium p-toluenesulfonate, 1, 2,3,3-tetramethyl-3H-indolium methanesulfonate, 1,3,3-trimethyl-2-methylenindoline (Fischer's base), 2,3-dimethylbenzothiazolium iodide, 2,3-dimethylbenzothiazolium p-toluenesulfonate, 2,3-dimethyl-naphtho [1,2-d] thiazolium p-toluenesulfonate, 3-ethyl-2-methylnaphtho [1,2-d] thiazolium p-toluenesulfonate, rhodanine, rhodanine-3-acetic acid, 1, 4-

Dimethylquinolinium iodide, 1, 2-dimethylquinolinium iodide, barbituric acid, thiobarbituric acid, 1,3-dimethylthiobarbituric acid, 1,3-diethylthiobarbituric acid, 1,3-diethylbarbituric acid, oxindole, 3-indoxylatoacetate, 2-coumaranone, 5-hydroxybenzoic acid 2-cumaranone, 6-hydroxy-2-cumaranone, 3-methyl-1-phenyl-pyrazolin-5-one, indan-1, 2-dione, indan-1, 3-dione, indan-1-one, benzoylacetonitrile, 3-dicyanomethylene-indan-1-one, 2-amino-4-imino-1,3-thiazoline hydrochloride, 5,5-dimethylcyclohexane-1,3-dione, 2H-1,4-benzoxazin-4H-3-one, 3-ethyl-2-methyl-benzoxazolium iodide, 3-ethyl-2-methylbenzothiazolium iodide, 1-ethyl-4-methyl-quinolinium iodide, 1-ethyl-2-methylquinolinium iodide, 1,2,3-trimethylquinoxaluminum iodide, 3-ethyl 2-methylbenzoxazolium p-toluenesulfonate, 3-ethyl-2-methylbenzothiazolium p-toluenesulfonate, 1-ethyl-4-methyl-quinolinium p-toluenesulfonate, 1-ethyl-2-methylquinolinium p-toluenesulfonate, and 1,2,3-trimethylquinoxaluminum p-toluenesulfonate.

In addition, the compositions according to the invention may contain further ingredients. For example, use of certain metal ions or complexes may be preferred to obtain intense colorations. Agents according to the invention which additionally contain Cu, Fe, Mn, Ru ions or complexes of these ions are preferred here. Preferred bleaching agents according to the invention additionally comprise Cu, Fe, Mn, Co, Ce, V, Ru or ions of complexes of these ions, with particularly preferred agents 0.0001 to 2.5 wt .-%, preferably 0.001 to 1 wt .-% of at least one compound from the group copper chloride (CuCl ₂ ), copper sulfate (CuSO ₄ ), iron (II) sulfate, manganese (II) sulfate, manganese (II) chloride, cobalt (II) chloride, cerium sulfate, cerium chloride , Vanadium sulfate, manganese dioxide (MnO ₂ ).

As a further constituent, the compositions according to the invention may contain at least one ammonium compound from the group of ammonium chloride, ammonium carbonate, ammonium bicarbonate, ammonium sulfate and / or ammonium carbamate in an amount of from 0.5 to 10, preferably from 1 to 5,% by weight, based on the total composition of the composition ,

Furthermore, the bleaching according to the invention other active ingredients, excipients and additives such as nonionic polymers such as vinylpyrrolidone / vinyl acrylate copolymers, polyvinylpyrrolidone and vinylpyrrolidone / vinyl acetate copolymers and polysiloxanes, cationic polymers such as quaternized cellulose ethers, polysiloxanes with quaternary groups, dimethyldiallylammonium chloride polymers , Acrylamide-dimethyldiallyl-ammonium chloride copolymers, diethyl sulfate quaternized dimethylamino-ethylmethacrylate-vinylpyrrolidone copolymers, vinylpyrrolidone-imidazolinium methochloride copolymers and quaternized polyvinyl alcohol, zwitterionic and amphoteric polymers such as acrylamidopropyltrimethylammonium chloride / acrylate copolymers and octylacrylamide / methylmethacrylate / tert-butylaminoethylmethacrylamide-hydroxypropylmethacrylate copolymers, anionic polymers such as polyacrylic acids, cross-linked polyacrylic acids, vinyl acetate / crotonic acid copolymers , Vinyl pyrrolidone / inyl acrylate copolymers,

Vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and acrylic acid / ethyl acrylate / N-tert-butyl acrylamide terpolymers, thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya Gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. For example, methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. B. bentonite or fully synthetic hydrocolloids such as polyvinyl alcohol, structurants such as maleic acid and lactic acid, hair conditioning compounds such as phospholipids, such as soybean lecithin, egg lecithin and cephalins, Protein hydrolysates, in particular elastin, collagen, keratin, milk protein, soy protein and

Wheat protein hydrolysates, their condensation products with fatty acids and quaternized

protein,

Perfume oils, dimethylisosorbide and cyclodextrins,

Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol, fiber structure-improving agents, in particular mono-, di- and oligosaccharides such as glucose, galactose, fructose, fructose and lactose, quaternized amines such as methyl-1-alkylamidoethyl -2-alkylimidazolinium methosulfate

Defoamers like silicones,

Dyes for staining the agent,

Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,

Light stabilizers, in particular derivatized benzophenones, cinnamic acid derivatives and

triazines,

Substances for adjusting the pH, such as conventional acids, in particular

Pleasure acids and bases,

Active ingredients such as allantoin, pyrrolidonecarboxylic acids and their salts, and bisabolol,

Vitamins, provitamins and vitamin precursors, in particular those of groups A, B ₃ , B ₅ , B ₆ ,

C, E, F and H,

Plant extracts such as extracts of green tea, oak bark, stinging nettle, witch hazel,

Hops, chamomile, burdock root, horsetail, hawthorn, lime blossom, almond, aloe vera,

Spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime,

Wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch, mallow,

Meadowfoam, Quendel, Yarrow, Thyme, Melissa, Hauhechel, Coltsfoot, Marshmallow,

Meristem, ginseng and ginger root ,.

Cholesterol,

Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,

Fats and waxes such as spermaceti, beeswax, montan wax and paraffins,

fatty acid,

Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,

Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates,

Hydrogencarbonates, guanidines, ureas and primary, secondary and tertiary phosphates,

Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers

Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,

pigments

Stabilizing agent for hydrogen peroxide and other oxidizing agents,

Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air, Antioxidants, included

With regard to further optional components as well as the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art, eg. B. Kh. Schrader, bases and formulations of cosmetics, 2nd edition, Hüthig book publisher, Heidelberg, 1989, referenced.

The compositions according to the invention may contain the ingredients in a suitable aqueous, alcoholic or aqueous-alcoholic carrier. For the purpose of hair coloring such carriers are, for example, creams, emulsions, gels or surfactant-containing foaming solutions, such as shampoos, foam aerosols or other preparations which are suitable for use on the hair. But it is also possible to provide a powdery or tablet-shaped formulation, which is preferred for Blondiermittel.

For the purposes of the present invention, aqueous-alcoholic solutions are to be understood as meaning aqueous solutions containing from 3 to 70% by weight of a C ₁ -C ₄ -alkoxyethane, in particular ethanol or isopropanol. The compositions according to the invention may additionally contain further organic solvents, for example methoxybutanol, benzyl alcohol, ethyl diglycol or 1,2-propylene glycol. Preference is given to all water-soluble organic solvents.

Preferred agents according to the invention are characterized in that they additionally contain a nonaqueous solvent, particularly preferred compositions according to the invention the solvent in a concentration of 0.1 to 30 weight percent, preferably in a concentration of 1 to 20 weight percent, most preferably in a concentration of 2 - 10 weight percent, each based on the agent included.

In further preferred agents according to the invention, the solvent is selected from ethanol, n-propanol, isoropanol, n-butanol, propylene glycol, n-butylene glycol, glycerol, diethylene glycol monoethyl ether, diethylene glycol mono-n-butyl ether, phenoxyethanol and benzyl alcohol and mixtures thereof.

The pH of the compositions according to the invention can be adjusted within a wide range by suitable ingredients such as acidifying agent or alkalizing agent.

Oxidative dyeing of the fibers can in principle be carried out with atmospheric oxygen in the presence of oxidation dye precursors. However, preferred is a chemical oxidizing agent used, especially if in addition to the coloring, a lightening effect on human hair is desired. This lightening effect may be desired regardless of the staining method. Accordingly, the presence of oxidation dye precursors is not a mandatory requirement for the use of oxidizing agents in the compositions according to the invention. Suitable oxidizing agents are persulfates, chlorites and in particular hydrogen peroxide or its addition products of urea, melamine and sodium borate.

However, according to the invention, the oxidation colorant can also be applied to the hair together with a catalyst which promotes the oxidation of the dye precursors, e.g. by atmospheric oxygen, activated. Such catalysts are e.g. Metal ions, iodides, quinones or certain enzymes.

Suitable metal ions are, for example, Zn ²⁺ , Cu ²⁺ , Fe ²⁺ , Fe ³⁺ , Mn ²⁺ , Mn ⁴⁺ , Li ⁺ , Mg ²⁺ , Ca ²⁺ and Al ³⁺ . Particularly suitable are Zn ²⁺ , Cu ²⁺ and Mn ²⁺ . The metal ions can in principle be used in the form of any physiologically acceptable salt or in the form of a complex compound. Preferred salts are the acetates, sulfates, halides, lactates and tartrates. By using these metal salts, both the formation of the dyeing can be accelerated and the color shade can be specifically influenced.

Suitable enzymes are e.g. Peroxidases that can significantly increase the effect of small amounts of hydrogen peroxide. Furthermore, such enzymes are suitable according to the invention which directly oxidize the oxidation dye precursors with the aid of atmospheric oxygen, such as, for example, the laccases, or generate small amounts of hydrogen peroxide in situ and thus biocatalytically activate the oxidation of the dye precursors. Particularly suitable catalysts for the oxidation of the dye precursors are the so-called 2-electron oxidoreductases in combination with the specific substrates, e.g.

Pyranose oxidase and e.g. D-glucose or galactose,

Glucose oxidase and D-glucose,

- glycerol oxidase and glycerin,

Pyruvate oxidase and pyruvic acid or its salts,

Alcohol oxidase and alcohol (MeOH, EtOH),

Lactate oxidase and lactic acid and their salts,

Tyrosinase oxidase and tyrosine,

Uricase and uric acid or their salts,

- choline oxidase and choline,

- amino acid oxidase and amino acids. In an application of oxidants, the actual colorant is conveniently prepared immediately prior to use by mixing the preparation of the oxidizing agent with the preparation containing the compounds of formula I and optionally dye precursors. The resulting ready-to-use hair dye preparation should preferably have a pH in the range of 6 to 12. Particularly preferred is the use of the hair dye in a weakly alkaline medium. The application temperatures can be in a range between 15 and 40 ⁰ C. After a contact time of 5 to 45 minutes, the hair dye is removed by rinsing of the hair to be dyed. The washing with a shampoo is omitted if a strong surfactant-containing carrier, such as a dyeing shampoo was used.

In particular, in the case of hair that is difficult to dye, an agent according to the invention may optionally be applied to the hair with additional dye precursors but also without prior mixing with the oxidation component. After an exposure time of 20 to 30 minutes, the oxidation component is then applied, if appropriate after an intermediate rinse. After a further exposure time of 10 to 20 minutes, the product is then rinsed and, if desired, shampooed again. In this embodiment, according to a first variant, in which the previous application of the dye precursors is intended to effect a better penetration into the hair, the corresponding agent is adjusted to a pH of about 4 to 7. According to a second variant, an air oxidation is initially desired, wherein the applied agent preferably has a pH of 7 to 10. In the subsequent accelerated post-oxidation, the use of acidified peroxydisulfate solutions may be preferred as the oxidizing agent.

For the application of the compositions of the invention on the hair bleaching agents are mixed immediately before application with a hydrogen peroxide solution. The concentration of this hydrogen peroxide solution is determined on the one hand by the legal requirements and on the other hand by the desired effect; As a rule, 6-12% solutions in water are used. The proportions of blonding agent and hydrogen peroxide solution are usually in the range 1: 1 to 1: 2, with an excess of hydrogen peroxide solution is particularly selected when no too pronounced Blondierwirkung is desired.

Also preferred according to the invention is the use of so-called complexing agents. Complex images are substances that can complex metal ions. Preferred complexing agents are so-called chelate complexing agents, ie substances which form cyclic compounds with metal ions, where a single ligand occupies more than one coordination site on a central atom, ie at least ^" bidentate". In this case, normally stretched compounds are closed by complex formation via an ion into rings. The number of bound ligands depends on the coordination number of the central ion.

Customary and preferred chelate complex images in the context of the present invention are, for example, polyoxycarboxylic acids, polyamines, ethylenediaminetetraacetic acid (EDTA), nitrilotriacetic acid (NTA) and hydroxyethanediphosphonic acids or their alkali metal salts. Also, complex-forming polymers, ie polymers which carry functional groups either in the main chain itself or laterally to it, which can act as ligands and react with suitable metal atoms usually with the formation of chelate complexes, can be used according to the invention. The polymer-bound ligands of the resulting metal complexes can originate from only one macromolecule or belong to different polymer chains. The latter leads to the crosslinking of the material, provided that the complex-forming polymers were not previously crosslinked via covalent bonds.

Complexing groups (ligands) of conventional complexing polymers are iminodiacetic acid, hydroxyquinoline, thiourea, guanidine, dithiocarbamate, hydroxamic acid, amidoxime, aminophosphoric acid, (cyclic) polyamino, mercapto, 1,3-dicarbonyl - And crown ether residues with z. T. very specific. Activities towards ions of different metals. Base polymers of many also commercially important complex-forming polymers are polystyrene, polyacrylates, polyacrylonitriles, polyvinyl alcohols, polyvinylpyridines and polyethyleneimines. Natural polymers such as cellulose, starch or chitin are also complex-forming polymers. In addition, these can be provided by polymer-analogous transformations with other ligand functionalities.

In the context of the present invention, it is particularly preferable to use one or more chelating agents from the groups of

(I) polycarboxylic acids in which the sum of the carboxyl and optionally

Hydroxyl groups is at least 5,

(ii) nitrogen-containing mono- or polycarboxylic acids,

(iii) geminal diphosphonic acids,

(iv) aminophosphonic acids,

(v) phosphonopolycarboxylic acids,

(vi) cyclodextrins. In the context of the present invention, all complexing agents of the prior art can be used. These can belong to different chemical groups. Preferably, used individually or in admixture with each other:

a) polycarboxylic acids in which the sum of the carboxyl and optionally hydroxyl groups is at least 5, such as gluconic acid, b) nitrogen-containing mono- or polycarboxylic acids, such as ethylenediaminetetraacetic acid (EDTA), N-hydroxyethylethylenediaminetriacetic acid, diethylenetriaminepentaacetic acid, hydroxyethyliminodiacetic acid, nitridodiacetic acid-3-propionic acid, isoserinediacetic acid, N , N-di (β-hydroxyethyl) glycine, N- (1, 2-dicarboxy-2-hydroxyethyl) glycine, N- (1, 2-dicarboxy-2-hydroxyethyl) aspartic acid or nitrilotriacetic acid (NTA), c) geminal diphosphonic acids such as 1-hydroxyethane-1, 1-diphosphonic acid (HEDP), their higher homologues having up to 8 carbon atoms and hydroxy- or amino-containing derivatives thereof and 1-aminoethane-1, 1-diphosphonic acid whose higher homologues with up to 8 carbon atoms and hydroxyl- or amino-containing derivatives thereof, d) aminophosphonic acids such as ethylenediaminetetra (methylenephosphonic acid), diethylenetriaminepenta (methyls nphosphonic acid) or nitrilotri (methylenephosphonic acid), e) phosphonopolycarboxylic acids such as 2-phosphonobutane-1, 2,4-tricarboxylic acid and f) cyclodextrins.

For the purposes of this patent application, polycarboxylic acids a) are understood as meaning carboxylic acids, including monocarboxylic acids, in which the sum of carboxyl and the hydroxyl groups contained in the molecule is at least 5. Complexing agents from the group of nitrogen-containing polycarboxylic acids, in particular EDTA, are preferred. In the case of the alkaline pH values of the treatment solutions required according to the invention, these complexing agents are at least partially present as anions. It is irrelevant whether they are introduced in the form of acids or in the form of salts. In the case of use as salts, alkali metal, ammonium or alkylammonium salts, in particular sodium salts, are preferred.

Also to be mentioned as further preferred complexing polymeric aminodicarboxylic acids, their salts or their precursors. Particular preference is given to polyaspartic acids or their salts and derivatives which, in addition to cobuilder properties, also have a bleach-stabilizing action.

Further suitable complexing agents are polyacetals which can be obtained by reacting dialdehydes with polyolcarboxylic acids which have 5 to 7 C atoms and at least 3 hydroxyl groups. Preferred polyacetals are selected from dialdehydes such as glyoxal, Glutaraldehyde, terephthalaldehyde and mixtures thereof and from Polyolcarbonsäuren such as Giuconsäure and / or glucoheptonic acid.

Another class of substances with complex-forming properties are the phosphonates. These are, in particular, hydroxyalkane or aminoalkanephosphonates. Among the hydroxyalkane phosphonates, 1-hydroxyethane-1,1-diphosphonate (HEDP) is of particular importance. It is preferably used as the sodium salt, the disodium salt neutral and the tetrasodium salt alkaline (pH 9). Preferred aminoalkane phosphonates are ethylenediamine tetramethylene phosphonate (EDTMP), diethylene triamine pentamethylene phosphonate (DTPMP) and their higher homologs. They are preferably in the form of neutral sodium salts, eg. B. as the hexasodium salt of EDTMP or as hepta- and octa-sodium salt of DTPMP used. The complexing agent used here is preferably HEDP from the class of phosphonates. The aminoalkanephosphonates also have a pronounced heavy metal binding capacity. Accordingly, in particular if the agents also contain bleach, it may be preferable to use aminoalkanephosphonates, in particular DTPMP, or to use mixtures of the phosphonates mentioned. These substances will be described below.

Compounds which are preferred according to the invention are phosphonates, preferably hydroxyalkane or aminoalkane phosphonates and in particular 1-hydroxyethane-1,1-diphosphonate (HEDP) or its di- or tetrasodium salt and / or ethylenediamine tetramethylene phosphonate (EDTMP) or its hexasodium salt and / or diethylene triamine pentamethylene phosphonate (DTPMP ) or its hepta- or octasodium salt.

From the above-mentioned groups of substances, some representatives are particularly preferred in the context of the present invention. Particularly preferred agents according to the invention contain one or more substances from the group

(a) nitrilotriacetic acid (NTA),

(b) diethylenetriaminepentaacetic acid (DTPA),

(c) ethylenediamine disuccinic acid (EDDS),

(d) ethylenediamine-diglutaric acid (EDGA),

(e) 2-hydroxypropylenediamine disuccinic acid (HPDS),

(f) glycinamide-N, N'-disuccinic acid (GADS),

(g) ethylenediamine-N-N'-diglutaric acid (EDDG),

(h) 2-Hydroxypropylenediamine-N-N'-dibemic acid (HPDDS), (i) Ethylenediaminetetraacetic acid (EDTA) ₁ (j) Ethylenedicysteic acid (EDC) ₁ (k) diaminoalkyldi (sulfosuccinic acid) (DDS),

(I) Ethylenediamine-N-N'-bis (ortho-hydroxyphenylacetic acid (EDDHA) ₁

(m) N-2-hydroxyethyl-N, N-diacetic acid,

(n) glyceryliminodiacetic acid,

(o) lminodiacetic acid N-2-hydroxypropylsulfonic acid,

(p) aspartic acid-N-carboxymethyl-N-2,5-hydroxypropyl-3-sulfonic acid,

(q) 8-alanine-N, N'-diacetic acid,

(r) aspartic acid-N, N'-diacetic acid,

(s) aspartic acid N-monoacetic acid,

(t) dipicolinic acid,

(u) and their salts and / or derivatives

Agents preferred according to the invention are characterized in that they additionally comprise one or more chelate complexing agents from the groups of

(i) polycarboxylic acids in which the sum of the carboxyl and optionally hydroxyl groups is at least 5,

(ii) nitrogen-containing mono- or polycarboxylic acids,

(iii) geminal diphosphonic acids,

(iv) aminophosphonic acids,

(v) phosphonopolycarboxylic acids,

(vi) cyclodextrins, preferred agents being phosphonates, preferably hydroxyalkane or aminoalkane phosphonates and especially 1-hydroxyethane-1,1-diphosphonate (HEDP) or its di- or tetrasodium salt and / or ethylenediamine tetramethylene phosphonate (EDTMP) or its hexasodium salt and or diethylenetriaminepentamethylenephosphonate (DTPMP) or its hepta- or octasodium salt.

In addition to the ingredients mentioned, the use of carbonates and crabonate analogues in the compositions according to the invention has proven to be preferred. Accordingly, preferred agents according to the invention additionally contain 0.1 to 25 wt.%, Preferably 0.5 to 20 wt.%, Particularly preferably 1 to 15 wt.% And in particular 1, 5 to 10 wt.% Of at least one substance from the groups of

Carbonates and / or

Monoalkyl carbonates (carbonic acid monoesters) and / or

Carbonic acid monoamides and / or

Silyl carbonates and / or

Silylcarbamate Particularly suitable carbonates are ammonium, alkali metal and alkaline earth metal carbonates and bicarbonates. For example, sodium bicarbonate, sodium carbonate are particularly preferred.

In addition to or in place of carbonates, the compositions according to the invention may preferably also contain at least one carbonic acid monoester and / or at least one carbonic acid monoamide. These substances are described in detail below.

Agents preferred according to the invention are characterized in that they contain at least one carbonic acid monoester of the formula (I)

R-O-C (O) -O-H (I)

in which R represents a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.

In formula (I), R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, amino, nitro, sulfonic acid groups or halogens as substituents. Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably, R is a C _1-6 alkyl group. Examples of inventive

The groups are methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, iso-pentyl and hexyl.

Particularly preferred agents according to the invention are characterized in that the radical R in formula (I) is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl as well as hydroxymethyl and hydroxyethyl radicals.

As an alternative to the carbonic acid monoester or in conjunction with it, the compositions according to the invention may contain carbonic acid monoamides. Here, preferred agents according to the invention are characterized in that they contain at least one carbonic acid monoamide of the formula (II)

R-NH-C (O) -OH (II) in which R is a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.

In formula (II), R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, amino, nitro, sulfonic acid groups or halogens as substituents. Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably R is a Cvβ-alkyl group. Examples of C-i-Cβ-alkyl groups according to the invention are the groups methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl and hexyl.

Particularly preferred agents according to the invention are characterized in that the radical R in formula (II) is selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, isobutyl, fe / t Butyl and hydroxymethyl and hydroxyethyl radicals.

The acidic H atom of the carbonic acid monoester or monoamide may also be in neutralized form, i. salts of carbonic acid monoesters or carbonic acid monoamides can also be used according to the invention. Here, agents according to the invention are preferred which contain the carbonic acid monoester or the carbonic acid monoamide in completely or partially neutralized form, preferably in the form of its alkali metal, ammonium, alkaline earth metal or aluminum salt and in particular in the form of its sodium salt.

Regardless of whether the compositions according to the invention comprise one or more carbonic acid monoesters and / or one or more carbonic acid monoamides, agents according to the invention are preferred which contain the carbonic acid monoester and / or carbonic acid monoamides in amounts of from 0.1 to 20% by weight, preferably from 0 , 5 to 18 wt.%, Particularly preferably from 2 to 15 wt.% And in particular from 5 to 12 wt.%, Each based on the total agent.

In addition to or in place of carbonates and / or carbonic acid monoesters and / or carbonic acid monoamides, the compositions according to the invention may preferably also contain at least one silyl carbonate and / or at least one silyl carbamate. These substances are described in detail below. Agents preferred according to the invention are characterized in that they contain at least one silyl carbonate of the formula (III)

R ²

R ¹ -Si-OC (O) -OR ⁴ (III)

R ³

in which the radicals R ¹ , R ² and R ³ independently of one another represent a hydrogen atom, a saturated or unsaturated, straight-chain, branched or cyclic, substituted or unsubstituted hydrocarbon radical or for a trialkylsilyl group, preferably a trimethylsilyl group or for a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle or a halogen, a substituted or unsubstituted hydroxy, oxo, amino, imino groups and the radical R ^{4 is} a chemical bond to the Si atom or to one of the radicals R ¹ , R ² or R ³ , a hydrogen atom, a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical or for a substituted or unsubstituted SiIyI or alumino group or for a substituted or unsubstituted aryl group or a substituted or unsubstituted He terocyclus stands.

Preferred radicals R ¹ , R ² and R ³ in the abovementioned formula (III) are substituted or unsubstituted, straight-chain or branched alkyl radicals. Among these, the alkyl radicals having 1 to 5 carbon atoms and the hydroxyalkyl radicals are preferred, so that preferred agents according to the invention are characterized in that the radicals R ¹ , R ² and R ³ in formula (I) are selected from methyl, ethyl, n Propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, hydroxymethyl and hydroxyethyl radicals.

Preferred radicals R ⁴ in the abovementioned formula (III) are hydrogen, substituted or unsubstituted, straight-chain or branched alkyl radicals and trialkylsilyl radicals. Among them, preferred are hydrogen, methyl, ethyl, tert-butyl and trimethylsilyl radicals.

The acidic H atom of the silyl carbonate (R ⁴ = -H in formula III) can also be present in neutralized form, ie according to the invention it is also possible to use salts of silyl carbonates. Here, agents according to the invention are preferred which comprise at least one silyl carbonate in completely or partially neutralized form, preferably in the form of its alkali metal, ammonium, alkaline earth metal or aluminum salt and in particular in the form of its sodium salt. In addition to the silylcarbonates or in their place, the compositions of the invention may contain silyl carbamates.

Agents preferred according to the invention are characterized in that they contain a silyl carbamate of the formula (IV)

R ²

IR ¹ -Si-OC (O) -NR ⁴ R ⁵ (IV)

R ³

containing, in which the radicals R ¹ , R ² and R ³ independently of one another represent a hydrogen atom, a saturated or unsaturated, straight-chain, branched or cyclic, substituted or unsubstituted hydrocarbon radical or for a trialkylsilyl group, preferably a trimethylsilyl group or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle or a halogen, a substituted or unsubstituted hydroxy, oxo, amino groups and the radicals R ⁴ and R ⁵ independently of one another for a chemical bond to the Si atom or to a the radicals R ¹ , R ² or R ³ , a hydrogen atom, a saturated or unsaturated, straight-chain, branched or cyclic, substituted or unsubstituted hydrocarbon radical or a substituted or unsubstituted SiIyI or alumino group or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.

Preferred radicals R ¹ , R ² and R ³ in the abovementioned formula (IV) are substituted or unsubstituted, straight-chain or branched alkyl radicals. Among these, the alkyl radicals having 1 to 5 carbon atoms and the hydroxyalkyl radicals are preferred, so that preferred agents according to the invention are characterized in that the radicals R ¹ , R ² and R ³ in formula (II) are selected from methyl, ethyl, n Propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, hydroxymethyl and hydroxyethyl radicals.

Preferred radicals R ⁴ and R ⁵ in the abovementioned formula (IV) are hydrogen, substituted or unsubstituted, straight-chain or branched alkyl radicals and trialkylsilyl radicals. Among them, preferred are hydrogen, methyl, ethyl, tert-butyl and trimethylsilyl radicals. Regardless of whether the compositions according to the invention contain one or more silyl carbonates and / or one or more silyl carbamates, agents according to the invention are preferred which contain the silyl carbonate (s) and / or silyl carbamate (s) in amounts of from 0.1 to 25% by weight .%, Preferably from 0.5 to 20 wt.%, Particularly preferably from 1 to 15 wt.% And in particular from 1, 5 to 10 wt.%, Each based on the total agent.

The agents according to the invention preferably have a pH of from 5.0 to 9.0, preferably from 5.5 to 8.0, particularly preferably from 6.0 to 7.7, more preferably from 6.2 to 7.2 and especially from 6.5 to 6.8.

Preferred agents according to the invention are formulated with little or no water. Particularly preferred agents according to the invention are characterized in that they contain less than 5% by weight, preferably less than 2% by weight, more preferably less than 1% by weight and in particular less than 0.5% by weight of water, preferred agents being anhydrous.

The water content of the agent can be determined, for example, by means of titration according to Karl Fischer.

A second object of the present invention is a method for lightening

Keratinfasern, in particular human hair, in which, if desired, a pretreatment agent M1 is applied to the fiber, then a means M2 is applied to the fiber, wherein, if desired, the means

M2 is added before use another agent M3, this agent M2 is rinsed from the fiber after a period of 5-30 minutes and after treatment optionally a post-treatment agent M4 applied to the fiber and rinsed after a contact time of a few minutes, wherein at least one of the means M1, M2 or M3 is an agent according to the invention.

The agents according to the invention can therefore be formulated as one-component agents (bleaching agent M2 or aftertreatment agent M4), as two-component agents (M2 + M3) or as three-component agents (M2 + M3 + M4) and used accordingly. Separation into multicomponent systems is particularly suitable where incompatibilities of the ingredients are to be expected or feared; the agent to be used in such systems is manufactured by the consumer just prior to use by mixing the component. A whitening process in which the whitening cream and the oxidizing agent are initially separate is preferred. A further subject of the present invention is therefore a process for whitening human hair, in which an aqueous-based composition containing hydrogen peroxide is mixed with an agent according to the invention to form a homogeneous composition and applied to the hair.

In preferred processes of this type according to the invention, the aqueous composition contains from 1 to 20% by weight, preferably from 2 to 10% by weight and in particular from 3 to 6% by weight of hydrogen peroxide, calculated as 100% H ₂ O ₂ .

Further preferred processes of this kind according to the invention are characterized in that the aqueous-based composition comprising hydrogen peroxide is mixed with an agent according to the invention in a weight ratio of 1: 5 to 10: 1, preferably 1: 2 to 5: 1 and in particular 1: 2 to 2: 1 mixed into a homogeneous composition, and this is applied to the hair.

Alternatively, as mentioned above, a three-component system may also be used. Another object of the present invention is therefore a process for whitening human hair, wherein an aqueous composition containing hydrogen peroxide, with a further agent containing preferably at least one alkalinity donor and / or direct hair dye and / or at least one oxidation dye precursor, and a Mixture of the invention mixed to form a homogeneous composition, and this is applied to the hair.

With regard to further preferred embodiments of the method according to the invention, mutatis mutandis the statements made concerning the agents according to the invention apply.

Another object of the present invention is the use of mixtures of a) at least one solid peroxo compound, which is selected from ammonium and alkali metal persulfates and peroxidisulfates, b1) at least one cyanate of the formula

M ⁺ [OCN] - wherein M ⁺ represents K ^+, Na ^+, Li ⁺ or NH ₄ ⁺ or VS Ca ^2+, ¹ / _2Mg ^2+, or Zn ²⁺ Vz and / or b2) at least one compound of formula

H ₂ NC (O) -L in which L stands for a group displaceable by the anion ^" OOH, in bleaching agents, preferably in weakly alkaline to neutral bleaching agents.

Particularly preferably, the use of the mixtures is the achievement of certain advantageous

Effects. Preferred according to the invention are uses for i. Increase in the whitening or bleaching performance and / or ii. Increase the skin compatibility of brightening or bleaching agents.

With regard to preferred uses according to the invention, the mutated mutandis applies to the preferred agents.

Examples:

a) Bleaching pastes:

Three bleaching pastes were prepared, the composition of which (in g) are given in Table 1:

Components E1 E2 E3

Ammonium peroxydisulfate 12.0 2.0

Potassium peroxydisulfate 4.5 2.0

Sodium peroxydisulfate 5.5 6.0

Britesil C20 2.5 2.5

Texapon K12 P 1, 0

Elfan AT 84 1, 0

Cetytrimethylammonium bromide 1, 0

Cetiol 868 8.1 6.9 9.1

Titanium dioxide 0.3 0.3 0.3

Lorol 2.0

Cutina GMS 0.4

Eutanol G 0.4

EDTA, disodium salt 0.5 0.5 0.5

Aerosil 200 0.1 0.1 0.1

Cekol 50,000 1, 0 1, 0 1, 0

Trisodium phosphate 1, 3

Sodium cyanate 0.2 0.3 0.1

Total 100 100 100

Britesil ^® C20 precipitated silica (INCI name: Silica) (PQ) Texapon ^® K12 P sodium dodecyl sulfate, powder (INCI name: Sodium Lauryl Sulfate Silica) (Cognis)

Elfan AT 84 ^® sodium cocoyl isethionate (INCI name Sodium Cocoyl Isethionate) (Julius Hoesch) Cetiol ^® 868 ethylhexyl stearate (INCI name: Ethyl hexyl Stearate) (Cognis)

Lorol® ^® tech. Ci ₂ -i ₈ fatty alcohol (INCI name: Coconut alcohol) (Cognis) Cutina ^® GMS Glycerin mono / dipalmitate / stearate (INCI name: Glyceryl Stearate) (Cognis) Eutanol ^® G 2-octyldodecyl alcohol (INCI name: Octyldodecanol) (Cognis)

Aerosil ^® 200 Fumed Silica (INCI name: Silica) (Degussa) Cekol ^® Carboxymethylcellulose (INCI name Cellulose Gum) (CP Kelco)

In addition, a developer dispersion of the following composition was prepared:

Texapon N28 2.0% by weight Turpinal SL 1.5% by weight hydrogen peroxide 12.0% by weight ammonia solution; 25% 0.65% by weight Acrysol 33 12.0% by weight water ad 100% by weight

Texapon ^® N28 lauryl ether sulfate sodium salt (at least 26.5%

Active substance content; INCI name: Sodium Laureth Sulfate) (Cognis)

Turpinal ^® SL 1-Hydroxyethane-1, 1-diphosphonic acid (about 58 - 61% active ingredient content, INCI name: Etidronic Acid, Aqua (Water)) (Solutia)

Acrysol ^® 33 acrylic polymer (about 28% solids in water, INCI name: acrylates copolymer)

Formulations 1 to 3 were mixed with the developer dispersion in a weight ratio of 1: 3 and, after mixing with phosphoric acid, adjusted to a pH of between 7 and 7.5.

On mittelblonden and dark brown hair of the codes Fischbach and Miller 6923 and Kerling 2/0 (45 minutes, 32 ° C, weight ratio application mixture / hair = 4: 1) resulted in much better brightening than the corresponding formulations without sodium cyanate.

b) bleaching powder:

A comparative bleaching powder according to the invention was prepared, the composition of which (in g) is given in Table 1: Components V1 E4

Ammonium peroxydisulfate 22.0 22.0

Potassium peroxydisulphate 22.0 22.0

Sodium peroxodisulfate 10.8 12.2

Sodium cyanate - 1, 0

Britesil C20 21, 0 22,6

Sodium stearate 8.0 8.0

Sodium C _16-18 alkyl sulfate 0.8 0.8

Calcium stearate 3,5 3,5

Magnesium oxide 1.7 1, 7

Magnesium hydroxide carbonate 0.7 0.7

EDTA ₁ disodium salt 0.5 0.5

Trisodium phosphate 4.0

Aerosil 200 3.0 3.0

Cetiol OE 2.0 2.0

Total 100 100

Britesil ^® C20 precipitated silica (INCI name

Aerosil ^® 200 fumed silica (INCI E 3ezeic

Cetiol ^® OE Dioctvlether (INCI Bezeichnu nq: Di <

50 g each of the powders were mixed with 50 g of the developer dispersion from a). The comparative mixture had a pH of 10, the mixture with the powder E4 was adjusted to a pH of 7.0 with phosphoric acid. With these mixtures hair strands of 0.5 g each weight of the codes Kerling 2/0 (dark brown) and Fischbach and Miller 6923 (dark blond) (45 minutes, 32 ⁰ C ₁ weight ratio application mixture / hair = 4: 1) dyed.

Both formulations gave excellent whitening results, i. with a neutral and substantially less hair damaging pH, the results of conventional high alkaline bleaching were achieved.

Claims

claims:

1. means for bleaching human hair, containing - in each case based on its weight - b. From 5 to 70% by weight of at least one solid peroxy compound selected from ammonium and alkali metal persulfates and peroxydisulfates, b1) from 0.05 to 5% by weight of at least one cyanate of the formula

M ⁺ [OCN] - in which M ^{+ stands} for K ⁺ , Na ⁺ , Li ⁺ or NH ₄ ⁺ or V ₂ Ca ²⁺ , V ₂ Mg ²⁺ or V ₂ Zn ²⁺ and / or b ₂ ) 0.05 to 5% by weight of at least one compound of the formula

H ₂ NC (O) -L in which L stands for a group displaceable by the anion ^" OOH.

2. Composition according to claim 1, characterized in that it contains 6 to 65 wt .-%, preferably 7.5 to 60 wt .-%, particularly preferably 8 to 55 wt .-% and in particular 10 to 50 wt .-% peroxydisulfate (e) contains.

3. Composition according to one of claims 1 or 2, characterized in that it contains sodium peroxydisulfate and / or potassium peroxydisulfate and / or ammonium peroxydisulfate, preferred agents containing at least two different Peroxidislfate.

4. Composition according to one of claims 1 to 3, characterized in that it contains 0.075 to 4% by weight, preferably 0.1 to 2.5 wt .-% and in particular 0.2 to 1 wt .-% sodium cyanate and / or potassium cyanate and / or ammonium cyanate, with sodium cyanate being particularly preferred.

5. Composition according to one of claims 1 to 4, characterized in that it is 0.075 to 4% by weight, preferably 0.1 to 3.5 wt .-% and in particular 0.2 to 3 wt .-% of at least one compound the formula

H _{2 contains} NC (O) -L in which L is selected from -S-CH ₂ -COOH, -S- (CH ₂ ) ₃ SO ₃ H, -S- (CH ₂ ) ₂ -NH ₂ , -OCH ₃ , -O- (C ₆ H ₄ ) -SO ₃ M, -Q ⁺ , -NH-OH, -O-C (O) -R ¹ , -O-C (O) -H, -O-CH (OH) ₂ , -SO ₃ M, -PH (O) OH, -P (O) (OH) ₂ , - (NH-Glucosamine) _n , -NH-C (O) -NH ₂ , -NH-NH ₂ , -NH-CN, -P (OH) (O) -C (O) NH ₂ , -SCN, -OCN, -SC (NH) NH ₂ , OONa ONH ₂

and M is -H ₁ Na, K, NH ₄ , Q is selected from quaternary ammonium radicals, heteroaryl radicals or non-aromatic heterocycles formed from tertiary amines and R ^{1 is} -H, -CH ₃ , -CH ₂ CH ₃ , - ( CH ₂ ) ₂ CH ₃ , -CH (CH ₃ ) ₂ or another alkyl group.

6. Composition according to one of claims 1 to 5, characterized in that it additionally contains Cu, Fe, Mn, Co, Ce, V, Ru ions or complexes of these ions, preferred agents 0.0001 to 2.5 wt .-%, preferably 0.001 to 1 wt .-% of at least one compound from the group copper chloride (CuCl ₂ ), copper sulfate (CuSO ₄ ), iron (II) sulfate, manganese (II) sulfate, manganese (II ) chloride, cobalt (II) chloride, cerium sulfate, cerium chloride, vanadium sulfate, manganese dioxide (MnO ₂ ).

7. Composition according to one of claims 1 to 6, characterized in that it additionally comprises one or more chelate complexing agents from the groups of

(ii) nitrogen-containing mono- or polycarboxylic acids,

(iii) geminal diphosphonic acids,

(iv) aminophosphonic acids,

(v) phosphonopolycarboxylic acids,

(vi) cyclodextrins, preferred agents being phosphonates, preferably hydroxyalkane or aminoalkane phosphonates and in particular 1-hydroxyethane-1,1-diphosphonate (HEDP) or its di- or tetrasodium salt and / or ethylenediamine tetramethylene phosphonate (EDTMP) or its hexasodium salt and or diethylenetriaminepentamethylenephosphonate (DTPMP) or its hepta- or octasodium salt.

8. Composition according to one of claims 1 to 7, characterized in that it additionally contains 0.1 to 25 wt.%, Preferably 0.5 to 20 wt.%, Particularly preferably 1 to 15 wt.% And in particular 1, 5 bis 10 wt.% Of at least one substance from the groups of Carbonates and / or

Monoalkyl carbonates (carbonic acid monoesters) and / or carbonic acid monoamides and / or silyl carbonates and / or silyl carbamates.

9. Composition according to one of claims 1 to 8, characterized in that it has a pH of 5.0 to 9.0, preferably from 5.5 to 8.0, particularly preferably from 6.0 to 7.7, more preferably from 6.2 to 7.2 and especially from 6.5 to 6.8.

10. Composition according to one of claims 1 to 9, characterized in that it is less than 5 wt .-%, preferably less than 2 wt .-%, more preferably less than 1 wt .-% and in particular less than 0.5 wt % Water, preferred agents being anhydrous.

11. A process for whitening keratin fibers, in particular human hair, characterized in that, if desired, a pretreatment agent M1 is applied to the fiber, then a means M2 is applied to the fiber, wherein if desired the

Agent M2 is added before use, a further agent M3, this agent M2 is rinsed from the fiber after a period of 5-30 minutes and after treatment optionally a post-treatment agent M4 on the

Fiber is applied and rinsed again after an exposure time of a few minutes, wherein at least one of the means M1, M2 or M3 is an agent according to one of claims 1 to

10 is.

12. Use of mixtures of a) at least one solid peroxo compound which is selected from ammonium and alkali metal persulfates and peroxidisulfates, b1) at least one cyanate of the formula

M ⁺ [OCN] ^" in which M is K, Na or NH ₄ and / or b2) at least one compound of the formula H ₂ NC (O) -L in which L is a group displaceable by the anion ^" OOH, in bleaching agents, preferably in slightly alkaline to neutral bleaching agents.

13. Use according to claim 12 for

Increase in the whitening or bleaching performance and / or

Increase the skin compatibility of brightening or bleaching agents.